0001604778-21-000032 | 10-K | XBRL Viewer

Document and Entity Information - USD ($)	12 Months Ended
Document and Entity Information - USD ($)	Apr. 03, 2021	May 13, 2021	Oct. 03, 2020
Document and Entity Information [Abstract]
Document Annual Report	true
City Area Code	336
Local Phone Number	664-1233
Title of 12(b) Security	Common Stock, $0.0001 par value
Entity Incorporation, State or Country Code	DE
Document Transition Report	false
Entity Central Index Key	0001604778
Entity File Number	001-36801
Document Period End Date	Apr. 03, 2021
Amendment Flag	false
Document Fiscal Period Focus	FY
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Tax Identification Number	46-5288992
Entity Address, Address Line One	7628 Thorndike Road
Entity Address, Postal Zip Code	27409-9421
Entity Address, City or Town	Greensboro,
Entity Address, State or Province	NC
Trading Symbol	QRVO
Security Exchange Name	NASDAQ
Document Fiscal Year Focus	2021
Document Type	10-K
Entity Registrant Name	Qorvo, Inc.
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Public Float			$ 14,839,992,498
Entity Common Stock, Shares Outstanding		112,586,812
Internal Control over Financial Reporting filed report	true
Current Fiscal Year End Date	--04-03

Consolidated Balance Sheets - USD ($) $ in Thousands	Apr. 03, 2021	Mar. 28, 2020
Current assets:
Cash and cash equivalents	$ 1,397,880	$ 714,939
Accounts receivable, net of allowance of $331 and $55 as of April 3, 2021 and March 28, 2020, respectively	457,431	367,172
Inventories	507,787	517,198
Prepaid expenses	41,572	37,872
Other receivables	27,324	15,016
Other current assets	51,810	38,305
Total current assets	2,483,804	1,690,502
Property and equipment, net	1,266,031	1,259,203
Goodwill	2,642,708	2,614,274
Intangible assets, net	611,155	808,892
Long-term investments	35,370	22,515
Other non-current assets	182,402	165,296
Total assets	7,221,470	6,560,682
Current liabilities:
Accounts payable	313,868	246,954
Accrued liabilities	255,060	217,801
Current portion of long-term debt	5,092	6,893
Other current liabilities	107,561	67,355
Total current liabilities	681,581	539,003
Long-term debt	1,742,550	1,567,231
Other long-term liabilities	167,914	161,783
Total liabilities	2,592,045	2,268,017
Commitments and contingent liabilities
Stockholders’ equity:
Preferred stock, $.0001 par value; 5,000 shares authorized; no shares issued and outstanding	0	0
Common stock and additional paid-in capital, $.0001 par value; 405,000 shares authorized; 112,557 and 114,625 shares issued and outstanding at April 3, 2021 and March 28, 2020, respectively	4,244,740	4,290,377
Accumulated other comprehensive income	29,649	2,288
Retained Earnings (Accumulated Deficit)	355,036	0
Total stockholders’ equity	4,629,425	4,292,665
Total liabilities and stockholders’ equity	$ 7,221,470	$ 6,560,682

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Apr. 03, 2021	Mar. 28, 2020
Statement of Financial Position [Abstract]
Allowance for accounts receivable	$ 331	$ 55
Preferred Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common stock, shares authorized	405,000,000	405,000,000
Common stock, shares issued	112,557,000	114,625,000
Common stock, shares outstanding	112,557,000	114,625,000

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Apr. 03, 2021	Mar. 28, 2020	Mar. 30, 2019
Income Statement [Abstract]
Revenue	$ 4,015,307	$ 3,239,141	$ 3,090,325
Cost of goods sold	2,131,741	1,917,378	1,895,142
Gross profit	1,883,566	1,321,763	1,195,183
Operating expenses:
Research and development	570,395	484,414	450,482
Selling, general and administrative	367,238	343,569	476,074
Other operating expense	39,306	70,564	52,161
Total operating expenses	976,939	898,547	978,717
Operating income	906,627	423,216	216,466
Interest expense	(75,198)	(60,392)	(43,963)
Other (expense) income	(24,049)	32,265	(80,711)
Income before income taxes	807,380	395,089	91,792
Income tax (expense) benefit	73,769	60,764	(41,333)
Net income	$ 733,611	$ 334,325	$ 133,125
Net income per share:
Basic	$ 6.43	$ 2.86	$ 1.07
Diluted	$ 6.32	$ 2.80	$ 1.05
Weighted average shares of common stock outstanding:
Basic	114,034	117,007	124,534
Diluted	116,016	119,293	127,356

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	12 Months Ended
	Apr. 03, 2021	Mar. 28, 2020	Mar. 30, 2019
Statement of Comprehensive Income [Abstract]
Net income	$ 733,611	$ 334,325	$ 133,125
Other comprehensive income (loss), net of tax:
Unrealized gain on available-for-sale debt securities	0	0	85
Change in pension liability	(597)	501	(651)
Foreign currency translation adjustment, including intra-entity foreign currency transactions that are of a long-term-investment nature	27,859	7,923	(3,396)
Reclassification adjustments, net of tax:
Foreign currency loss realized upon liquidation of subsidiary	16	353	0
Amortization of pension actuarial loss	83	135	90
Other comprehensive income (loss)	27,361	8,912	(3,872)
Total comprehensive income	$ 760,972	$ 343,237	$ 129,253

Consolidated Statements of Shareholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member]	Accumulated Other Comprehensive (Loss) Income	Accumulated Deficit
Common Stocks, Including Additional Paid in Capital	$ 5,237,085
Accumulated Other Comprehensive Income (Loss), Net of Tax	(2,752)
Retained Earnings (Accumulated Deficit)	(458,769)
Beginning Balance at Mar. 31, 2018	$ 4,775,564
Beginning Balance, Shares at Mar. 31, 2018	126,322
Net income	$ 133,125	$ 0	$ 0	$ 133,125
Other comprehensive income (loss)	(3,872)	0	(3,872)	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes	$ (10,833)	(10,833)	0	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes, Shares	1,368
Issuance of common stock in connection with employee stock purchase plan	$ 26,817	26,817	0	0
Issuance of common stock in connection with employee stock purchase plan, Shares	468
Repurchase of common stock, including transaction costs	$ (638,074)	(638,074)	0	0
Stock-based compensation expense	72,460	72,460	0	0
Cumulative-effect adoption of ASU 2014-09	$ 4,492	0	0	4,492
Repurchase of common stock, including transaction costs, Shares	(9,095)
Ending Balance at Mar. 30, 2019	$ 4,359,679
Ending Balance, Shares at Mar. 30, 2019	119,063
Common Stocks, Including Additional Paid in Capital	$ 4,687,455
Accumulated Other Comprehensive Income (Loss), Net of Tax	(6,624)
Retained Earnings (Accumulated Deficit)	(321,152)
Net income	334,325	0	0	334,325
Other comprehensive income (loss)	8,912	0	8,912	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes	$ (974)	(974)	0	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes, Shares	1,551
Issuance of common stock in connection with employee stock purchase plan	$ 28,657	28,657	0	0
Issuance of common stock in connection with employee stock purchase plan, Shares	452
Repurchase of common stock, including transaction costs	$ (515,131)	(501,868)	0	(13,263)
Stock-based compensation expense	77,107	77,107	0	0
Cumulative-effect adoption of ASU 2016-02	$ 69	0	0	69
Repurchase of common stock, including transaction costs, Shares	(6,441)
Other Retained Earnings Adjustment	$ 21	0	0	21
Ending Balance at Mar. 28, 2020	$ 4,292,665
Ending Balance, Shares at Mar. 28, 2020	114,625
Common Stocks, Including Additional Paid in Capital	$ 4,290,377
Accumulated Other Comprehensive Income (Loss), Net of Tax	2,288
Retained Earnings (Accumulated Deficit)	0
Net income	733,611	0	0	733,611
Other comprehensive income (loss)	27,361	0	27,361	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes	$ (29,163)	(29,163)	0	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes, Shares	1,157
Issuance of common stock in connection with employee stock purchase plan	$ 31,366	31,366	0	0
Issuance of common stock in connection with employee stock purchase plan, Shares	417
Cumulative-effect adoption of ASU 2016-13	$ (38)	0	0	(38)
Repurchase of common stock, including transaction costs	(515,084)	(136,568)	0	(378,516)
Stock-based compensation expense	$ 88,728	$ 88,728	$ 0	0
Repurchase of common stock, including transaction costs, Shares	(3,642)
Other Retained Earnings Adjustment	$ (21)			$ (21)
Ending Balance at Apr. 03, 2021	$ 4,629,425
Ending Balance, Shares at Apr. 03, 2021	112,557
Common Stocks, Including Additional Paid in Capital	$ 4,244,740
Accumulated Other Comprehensive Income (Loss), Net of Tax	29,649
Retained Earnings (Accumulated Deficit)	$ 355,036

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Apr. 03, 2021	Mar. 28, 2020	Mar. 30, 2019
Cash flows from operating activities:
Net income	$ 733,611	$ 334,325	$ 133,125
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	203,206	221,632	208,646
Intangible assets amortization	252,898	247,299	454,451
Loss on debt extinguishment	61,991	0	90,201
Deferred income taxes	(18,136)	(11,099)	(70,169)
Gain on Cavendish investment	0	(43,008)	0
Impairment of equity investment	2,775	18,339	0
Asset impairment	0	1,057	15,901
Stock-based compensation expense	89,322	75,978	71,580
Other, net	(2,151)	22,474	2,711
Changes in operating assets and liabilities:
Accounts receivable, net	(91,275)	21,029	(32,119)
Inventories	9,390	10,252	(39,590)
Prepaid expenses and other assets	(18,490)	(14,513)	13,343
Accounts payable	34,201	15,425	15,167
Accrued liabilities	30,671	48,670	(3,899)
Income taxes payable and receivable	34,618	12,935	(38,206)
Other liabilities	(20,778)	(15,149)	(10,778)
Net cash provided by operating activities	1,301,853	945,646	810,364
Investing activities:
Purchases of property and equipment	(186,960)	(164,104)	(220,937)
Purchases of available-for-sale debt securities	0	0	(132,732)
Proceeds from sales and maturities of available-for-sale debt securities	0	1,950	133,132
Purchases of businesses, net of cash acquired	(47,069)	(946,043)	0
Other investing activities	15,371	2,455	(27,017)
Net cash used in investing activities	(218,658)	(1,105,742)	(247,554)
Financing activities:
Repurchase and payment of debt	(1,087,994)	0	(1,050,680)
Proceeds from borrowings and debt issuances (Note 9)	1,206,750	659,000	905,350
Repurchase of common stock, including transaction costs	(515,084)	(515,131)	(638,074)
Proceeds from the issuance of common stock	42,598	50,198	41,289
Tax withholding paid on behalf of employees for restricted stock units	(38,658)	(21,791)	(24,835)
Other financing activities	(9,535)	(6,717)	(9,714)
Net cash (used in) provided by financing activities	(401,923)	165,559	(776,664)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	1,425	(1,233)	(1,166)
Net increase (decrease) in cash, cash equivalents and restricted cash	682,697	4,230	(215,020)
Cash, cash equivalents and restricted cash at the beginning of the period	715,612	711,382	926,402
Cash, cash equivalents and restricted cash at the end of the period	1,398,309	715,612	711,382
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	1,398,309	711,382	926,402
Interest Paid, Excluding Capitalized Interest, Operating Activities	81,232	48,871	56,039
Cash paid during the year for income taxes, net of refunds	53,236	55,513	69,453
Capital Expenditures Incurred but Not yet Paid	$ 56,469	$ 22,904	$ 37,728

The Company and Its Significant Accounting Policies	12 Months Ended
The Company and Its Significant Accounting Policies	Apr. 03, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
THE COMPANY AND ITS SIGNIFICANT ACCOUNTING POLICIES	THE COMPANY AND ITS SIGNIFICANT ACCOUNTING POLICIES Qorvo, Inc. was formed as the result of a business combination (the "Business Combination") of RF Micro Devices, Inc. ("RFMD") and TriQuint Semiconductor, Inc. ("TriQuint"), which closed on January 1, 2015. The Company is a leader in the development and commercialization of technologies and products for wireless and wired connectivity. We combine highly differentiated technologies, systems-level expertise and manufacturing scale to serve a diverse set of customers a broad portfolio of innovative solutions that enable a more connected world. The Company’s design expertise and manufacturing capabilities span multiple semiconductor process technologies. The Company's primary wafer fabrication facilities are in North Carolina, Oregon and Texas, and its primary assembly and test facilities are in China, Costa Rica, Germany and Texas. The Company also sources products and materials through external suppliers. The Company operates design, sales and other manufacturing facilities throughout Asia, Europe and North America. Principles of Consolidation and Basis of Presentation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Certain items in the fiscal years 2020 and 2019 financial statements have been reclassified to conform to the fiscal 2021 presentation. Accounting Periods The Company uses a 52- or 53-week fiscal year ending on the Saturday closest to March 31 of each year. The most recent three fiscal years ended on April 3, 2021, March 28, 2020 and March 30, 2019. Fiscal 2021 was a 53-week year and fiscal years 2020 and 2019 were 52-week years. Use of Estimates The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and the disclosure of contingent liabilities. The Company evaluates its estimates on an ongoing basis, including those related to revenue recognition, product warranty obligations, valuation of inventories, tax related contingencies, valuation of long-lived and intangible assets, other contingencies and litigation, among others. The Company generally bases its estimates on historical experience, expected future conditions and third-party evaluations. Accounting estimates require difficult and subjective judgments and actual results may differ from the Company’s estimates, particularly in light of the uncertainty relating to the impact of the COVID-19 pandemic. Certain accounting estimates that generally require consideration of expected future conditions were assessed by taking into account anticipated impacts from the COVID-19 pandemic as of April 3, 2021 and through the date of this Annual Report on Form 10-K using reasonably available information as of those dates. Cash and Cash Equivalents Cash and cash equivalents consist of demand deposit accounts, money market funds, and other temporary, highly liquid investments with original maturities of three months or less when purchased. Investments Marketable equity securities consist of common stock in publicly-traded companies and are carried at fair value with both the realized and unrealized gains and losses reported in "Other (expense) income, net." Fair values of publicly-traded equity securities are determined using quoted prices in active markets. The marketable equity securities are classified as short-term based on their highly liquid nature and are recorded in "Other current assets" in the Consolidated Balance Sheets. The Company invests in limited partnerships which are accounted for using the equity method. These equity method investments are classified as "Long-term investments" in the Consolidated Balance Sheets. The Company records its share of the financial results of the limited partnerships in "Other (expense) income, net" in the Company's Consolidated Statements of Income. The Company also invests in privately held companies for which the fair value of the investment is not readily determinable. These equity investments without a readily determinable fair value are measured at cost less impairment, adjusted for any changes in observable prices, and are classified as "Long-term investments" in the Consolidated Balance Sheets. The Company assesses these investments for impairment on a quarterly basis and considers both qualitative and quantitative factors that may have a significant impact on the investee's fair value. Qualitative factors considered include the investee's financial condition and business outlook, market for technology and other relevant events and factors affecting the investee. Investments are impaired when their fair value is less than their carrying value. Fair Value Measurement The Company measures and reports certain financial assets and liabilities on a recurring basis. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company categorizes its financial instruments carried at fair value into a three-level fair value hierarchy, based on the priority of inputs to the respective valuation technique. The three-level hierarchy for fair value measurement is described as follows: •Level 1 - includes instruments for which inputs are quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. •Level 2 - includes instruments for which the inputs are other than quoted prices that are observable for the asset or liability, either directly or indirectly, and fair value can be determined through the use of models or other valuation methodologies that do not require significant judgment since the inputs are corroborated by readily observable data. •Level 3 - includes instruments for which the valuations are based on inputs that are unobservable and significant to the overall fair value measurement. These inputs are supported by little or no market activity and reflect the use of significant management judgment. The Company also holds assets whose fair value is measured and recorded on a nonrecurring basis. These assets include equity method investments, equity investments without a readily determinable fair value, and certain non-financial assets, such as intangible assets and property and equipment. See Note 7 for further information on equity method investments and equity investments without a readily determinable fair value and Note 12 for further information on impairment of property and equipment. The carrying values of cash, cash equivalents and restricted cash, accounts receivable, accounts payable and other accrued liabilities approximate fair values because of the relatively short-term maturities of these instruments. See Note 9 for further disclosures related to the fair value of the Company's long-term debt. Inventories Inventories are stated at the lower of cost or net realizable value (cost is based on standard cost, which approximates actual average cost). Cost includes labor, materials and manufacturing overhead related to the purchase and production of inventories. Abnormal production levels are charged to "Cost of goods sold" in the period incurred rather than as a portion of inventory cost. The Company’s business is subject to the risk of technological and design changes. The Company evaluates inventory levels quarterly against demand forecasts on a material or product family basis to evaluate its overall inventory risk. Reserves are adjusted to reflect inventory values in excess of demand forecasts and management's analysis and assessment of overall inventory risk. In the event the Company sells inventory that had been covered by a specific inventory reserve, the sale is recorded at the actual selling price and the related cost of goods sold is recorded at the full inventory cost, net of the reserve. Product Warranty The Company generally sells products with a limited warranty on product quality. The Company accrues for known warranty issues if a loss is probable and can be reasonably estimated and accrues for estimated incurred but unidentified issues based on historical activity. The accrual and the related expense for known product warranty issues were not significant during the periods presented. Due to product testing and the short time typically between product shipment and the detection and correction of product failures and the historical rate of losses, the accrual and related expense for estimated incurred but unidentified issues was also not significant during the periods presented. Property and Equipment Property and equipment are stated at cost, less accumulated depreciation. Depreciation of property and equipment is computed using the straight-line method over the estimated useful lives of the assets, ranging from one year to 39 years. The Company capitalizes interest on borrowings related to eligible capital expenditures. Capitalized interest is added to the cost of qualified assets and depreciated together with that asset cost. The Company’s assets acquired under finance leases and leasehold improvements are amortized over the lesser of the asset life or lease term (which is reasonably assured) and included in depreciation. The Company records capital-related government grants earned as a reduction to property and equipment and depreciates such grants over the estimated useful lives of the associated assets. The Company periodically evaluates the period over which it expects to recover the economic value of the Company’s property and equipment, considering factors such as changes in machinery and equipment technology, the ability to re-use equipment across generations of process technology and historical usage trends. If the Company determines that the useful lives of its assets are shorter or longer than originally estimated, the rate of depreciation is adjusted to reflect the revised useful lives of the assets. The Company assesses property and equipment for impairment when events or changes in circumstances indicate that the carrying amount of its assets may not be recoverable. Factors that are considered in deciding when to perform an impairment review include an adverse change in the use of the Company’s assets or an expectation that the assets will be sold or otherwise disposed. The Company assesses the recoverability of the assets held and used by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining estimated useful lives against their respective carrying amounts. Assets identified as "held for sale" are recorded at the lesser of their carrying value or their fair market value less costs to sell. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets. Leases The Company determines that a contract contains a lease at lease inception if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. In evaluating whether the right to control an identified asset exists, the Company assesses whether it has the right to direct the use of the identified asset and obtain substantially all of the economic benefit from the use of the identified asset. Right-of-use assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. The Company uses its estimated incremental borrowing rate in determining the present value of lease payments considering the term of the lease, which is derived from information available at the lease commencement date. The lease term includes renewal options when it is reasonably certain that the option will be exercised and excludes termination options. To the extent that the Company's agreements have variable lease payments, the Company includes variable lease payments that depend on an index or a rate and excludes those that depend on facts or circumstances occurring after the commencement date, other than the passage of time. The Company elected the practical expedient not to separate lease and non-lease components for substantially all of its classes of leases and to account for the combined lease and non-lease components as a single lease component. In addition, the Company made an accounting policy election to exclude leases with an initial term of 12 months or less from the balance sheet. Business Acquisitions The Company allocates the fair value of the purchase price to the assets acquired and liabilities assumed based on their estimated fair value. The excess of the purchase price over the fair values of the identifiable assets and liabilities is recorded to goodwill. Goodwill is assigned to the Company's reporting unit that is expected to benefit from the synergies of the business combination. A number of assumptions, estimates and judgments are used in determining the fair value of acquired assets and liabilities, particularly with respect to the intangible assets acquired. The valuation of intangible assets requires the Company to use valuation techniques such as the income approach. The income approach includes management’s estimation of future cash flows (including expected revenue growth rates and profitability), the underlying product or technology life cycles and the discount rates applied to future cash flows. Judgment is also required in estimating the fair values of deferred tax assets and liabilities, uncertain tax positions and tax-related valuation allowances, which are initially estimated as of the acquisition date, as well as inventory, property and equipment, pre-existing liabilities or legal claims, deferred revenue and contingent consideration, each as may be applicable. While the Company uses its best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date as well as contingent consideration, where applicable, the Company’s estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. After the measurement period, any purchase price adjustments are recognized in the Consolidated Statements of Income. Goodwill The Company performs an annual impairment assessment of goodwill at the reporting unit level on the first day of the fourth quarter in each fiscal year, or more frequently if indicators of potential impairment exist. In accordance with Accounting Standards Codification ("ASC") 350, the Company may assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value, including goodwill. In performing a qualitative assessment, the Company considers (i) its overall historical and projected future operating results, (ii) if there was a significant decline in the Company’s stock price for a sustained period, (iii) if there was a significant change in the Company’s market capitalization relative to its net book value, and (iv) if there was a prolonged or more significant slowdown in the worldwide economy of the semiconductor industry, as well as other relevant events and factors affecting the reporting unit. If the Company assesses these qualitative factors and concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, or if the Company decides not to perform a qualitative assessment, then a quantitative impairment test is performed. In fiscal years 2021 and 2019, the Company completed qualitative assessments and concluded that based on the relevant facts and circumstances, it was more likely than not that each reporting unit’s fair value exceeded its related carrying value and no further impairment testing was required. In fiscal 2020, the Company performed a quantitative impairment test. The Company’s quantitative impairment test considered both the income approach and the market approach to estimate each reporting unit’s fair value. The resulting fair value, based on the income and market approaches, was then compared to the carrying value to determine if impairment is necessary. As a result of the quantitative analysis performed, it was determined that the fair value of each of the Company’s reporting units substantially exceeded their carrying values. Identified Intangible Assets The Company amortizes finite-lived intangible assets (including developed technology, customer relationships, technology licenses, backlog and trade names) over their estimated useful life. In-process research and development ("IPRD") assets represent the fair value of incomplete research and development ("R&D") projects that had not reached technological feasibility as of the date of the acquisition and are initially not subject to amortization. Upon completion of development, IPRD assets are transferred to developed technology and are amortized over their useful lives. The asset balances relating to abandoned projects are impaired and expensed to R&D. The Company performs a quarterly review of significant intangible assets to determine whether facts and circumstances (including external factors such as industry and economic trends and internal factors such as changes in the Company’s business strategy and forecasts) indicate that the carrying amount of the assets may not be recoverable. If such facts and circumstances exist, the Company assesses the recoverability of identified intangible assets by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining lives against their respective carrying amounts. Impairments, if any, are based on the excess of the carrying amounts over the fair value of those assets and occur in the period in which the impairment determination was made. Accrued Liabilities The "Accrued liabilities" balance as of April 3, 2021 and March 28, 2020, includes accrued compensation and benefits of $135.4 million and $126.1 million, respectively, and interest payable of $17.5 million and $22.8 million, respectively. Revenue Recognition The Company generates revenue primarily from the sale of semiconductor products, either directly to a customer or to a distributor, or at completion of a consignment process. Revenue is recognized when control of the promised goods or services is transferred to the Company's customers, in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. A majority of the Company's revenue is recognized at a point in time, either on shipment or delivery of the product, depending on individual customer terms and conditions. Revenue from sales to the Company’s distributors is recognized upon shipment of the product to the distributors (sell-in). Revenue is recognized from the Company’s consignment programs at a point in time when the products are pulled from consignment inventory by the customer. Revenue recognized for products and services over time is immaterial (less than 2% of overall revenue). The Company applies a five-step approach as defined in ASC 606, "Revenue from Contracts with Customers," in determining the amount and timing of revenue to be recognized: (1) identifying the contract with a customer; (2) identifying the performance obligations in the contract; (3) determining the transaction price; (4) allocating the transaction price to the performance obligations in the contract; and (5) recognizing revenue when the corresponding performance obligation is satisfied. Sales agreements are in place with certain customers and contain terms and conditions with respect to payment, delivery, warranty and supply, but typically do not require minimum purchase commitments. In the absence of a sales agreement, the Company’s standard terms and conditions apply. The Company considers a customer's purchase order, which is governed by a sales agreement or the Company’s standard terms and conditions, to be the contract with the customer. The Company’s pricing terms are negotiated independently, on a stand-alone basis. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which the Company expects to be entitled. Variable consideration in the form of rebate programs is offered to certain customers, including distributors, and represents less than 7% of net revenue. The Company determines variable consideration by estimating the most likely amount of consideration it expects to receive from the customer. The Company's terms and conditions do not give its customers a right of return associated with the original sale of its products. However, the Company may authorize sales returns under certain circumstances, which include courtesy returns and like-kind exchanges. The Company reduces revenue and records reserves for product returns and allowances, rebate programs and scrap allowance based on historical experience or specific identification depending on the contractual terms of the arrangement. The Company’s accounts receivable balance is from contracts with customers and represents the Company’s unconditional right to receive consideration from its customers. Payments are due upon completion of the performance obligation and subsequent invoicing. Substantially all payments are collected within the Company’s standard terms, which do not include any financing components. To date, there have been no material impairment losses on accounts receivable. Contract assets and contract liabilities recorded on the Consolidated Balance Sheets were immaterial as of April 3, 2021 and March 28, 2020. The Company invoices customers upon shipment and recognizes revenues in accordance with delivery terms. As of April 3, 2021, the Company had $87.5 million in remaining unsatisfied performance obligations with an original duration greater than one year, of which the majority is expected to be recognized as income over the next 12 months. The Company includes shipping charges billed to customers in "Revenue" and includes the related shipping costs in "Cost of goods sold" in the Consolidated Statements of Income. Taxes assessed by government authorities on revenue-producing transactions, including tariffs, value-added and excise taxes, are excluded from revenue in the Consolidated Statements of Income. The Company incurs commission expense that is incremental to obtaining contracts with customers. Sales commissions (which are recorded in the "Selling, general and administrative" expense line item in the Consolidated Statements of Income) are expensed when incurred because such commissions are not owed until the performance obligation is satisfied, which coincides with the end of the contract term, and therefore, no remaining period exists over which to amortize the commissions. Research and Development The Company charges all R&D costs to expense as incurred. Income Taxes The Company accounts for income taxes under the liability method, which requires recognition of deferred tax assets and liabilities for the temporary differences between the financial reporting and tax basis of assets and liabilities and for tax carryforwards. Deferred tax assets and liabilities for each tax jurisdiction are measured using the enacted statutory tax rates in effect for the years in which the differences are expected to reverse. A valuation allowance is provided against deferred tax assets to the extent the Company determines it is more likely than not that some portion or all of its deferred tax assets will not be realized. A more likely than not recognition threshold is required to be met before the Company recognizes the benefit of an income tax position in its financial statements. The Company’s policy is to recognize accrued interest and penalties, if incurred, on any unrecognized tax benefits as a component of income tax expense. It is the Company’s current intent and policy to repatriate certain previously taxed earnings of foreign subsidiaries from outside the U.S. Accordingly, the Company recognizes a deferred tax liability for income taxes on certain unremitted foreign earnings of foreign subsidiaries. For earnings which remain permanently reinvested, it is not practical to estimate the additional tax that would be incurred, if any, if the permanently reinvested earnings were repatriated. Stock-Based Compensation Under ASC 718, "Compensation – Stock Compensation," stock-based compensation cost is measured at the grant date, based on the estimated fair value of the award using an option pricing model for stock options (Black-Scholes) and market price for restricted stock units, and is recognized as expense over the employee's requisite service period. As of April 3, 2021, total remaining unearned compensation cost related to unvested restricted stock units was $103.7 million, which will be amortized over the weighted-average remaining service period of approximately 1.2 years. Foreign Currency Translation The financial statements of foreign subsidiaries have been translated into U.S. dollars in accordance with ASC 830, "Foreign Currency Matters." The functional currency for most of the Company’s international operations is the U.S. dollar. The functional currency for the remainder of the Company’s foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rates on the balance sheet dates. Revenues and expenses are translated using the weighted average exchange rates throughout the year. Translation adjustments are shown separately as a component of "Accumulated other comprehensive income" within "Stockholders’ equity" in the Consolidated Balance Sheets. Foreign currency transaction gains or losses (transactions denominated in a currency other than the functional currency) are reported in "Other (expense) income, net" in the Consolidated Statements of Income. Accounting Pronouncements Recently Adopted In June 2016, the Financial Accounting Standards Board issued Accounting Standards Update ("ASU") 2016-13, "Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments," which requires a current lifetime expected credit loss methodology to be used to measure impairments of accounts receivable and other financial assets. Using this methodology will result in earlier recognition of losses than under the previous incurred loss approach, which requires waiting to recognize a loss until it is probable of being incurred. The Company adopted this standard using the modified retrospective transition method, in the first quarter of fiscal 2021, which resulted in a cumulative-effect adjustment to retained earnings of less than $0.1 million. Under this new standard, the Company's trade receivables are now evaluated on a collective (pool) basis and aggregated on the basis of similar risk characteristics. These aggregated risk pools will be reassessed at each measurement date. A combination of factors is considered in determining the appropriate estimate of expected credit losses which include broad-based economic indicators as well as customers' financial strength, credit standing, payment history and any historical defaults. The adoption of this standard did not have a material impact on the Company's consolidated financial statements.

Concentrations of Credit Risk	12 Months Ended
Concentrations of Credit Risk	Apr. 03, 2021
Risks and Uncertainties [Abstract]
CONCENTRATIONS OF CREDIT RISK	CONCENTRATIONS OF CREDIT RISK The Company’s principal financial instrument subject to potential concentration of credit risk is accounts receivable, which is unsecured. The Company provides an allowance for doubtful accounts equal to estimated losses expected to be incurred in the collection of accounts receivable. The Company's trade receivables are evaluated on a collective (pool) basis and aggregated on the basis of similar risk characteristics, adjusting for broad-based economic indicators as well as customer specific factors. The Company has adopted credit policies and standards intended to accommodate industry growth and inherent risk and it believes that credit risks are moderated by the financial stability of its major customers, conservative payment terms and the Company’s strict credit policies. The Company provides products to its largest end customer, Apple Inc. through sales to multiple contract manufacturers, which in the aggregate accounted for approximately 30%, 33% and 32% of total revenue in fiscal years 2021, 2020 and 2019, respectively. Huawei Technologies Co., Ltd. and affiliates ("Huawei") accounted for less than 5%, 10% and 15% of total revenue in fiscal years 2021, 2020 and 2019, respectively. These customers primarily purchase radio frequency ("RF") solutions for a variety of mobile devices. In May 2019, the Bureau of Industry and Security of the U.S. Department of Commerce ("Commerce") added Huawei Technologies Co., Ltd. and over 100 of its affiliates to the Entity List maintained by Commerce, which caused the Company to temporarily suspend the export, reexport, and transfer of products to Huawei. In August 2020, Commerce issued a final rule adding additional Huawei non-U.S. affiliates to the Entity List, confirming the expiration of a temporary general license applicable to Huawei, and amending the foreign-produced direct product rule in a manner that represents a significant expansion of its application to Huawei. While the Company was able to ship certain products to Huawei in fiscal years 2021 and 2020, trade restrictions and the ability to secure any required licenses will continue to impact sales to Huawei. The Company's three largest accounts receivable balances comprised approximately 58% and 49% of aggregate gross accounts receivable as of April 3, 2021 and March 28, 2020, respectively.

Inventories

12 Months Ended

Apr. 03, 2021

Inventory Disclosure [Abstract]

INVENTORIES

The components of inventories, net of reserves, are as follows (in thousands):


	April 3, 2021		March 28, 2020
Raw materials	$	134,959	$	112,671
Work in process	283,067		291,028
Finished goods	89,761		113,499
Total inventories	$	507,787	$	517,198

Property and Equipment

12 Months Ended

Apr. 03, 2021

Property, Plant and Equipment [Abstract]

Property and Equipment

PROPERTY AND EQUIPMENT

The components of property and equipment are as follows (in thousands):


	April 3, 2021		March 28, 2020
Land	$	25,842	$	25,842
Building and leasehold improvements	411,180		404,075
Machinery and equipment	2,282,059		2,145,511


Construction in progress	108,563		99,172
Total property and equipment, gross	2,827,644		2,674,600
Less accumulated depreciation	(1,561,613)		(1,415,397)
Total property and equipment, net	$	1,266,031	$	1,259,203

Business Acquisitions

12 Months Ended

Apr. 03, 2021

BUSINESS ACQUISITION DISCLOSURE [Abstract]

BUSINESS ACQUISITIONS

During fiscal 2021, the Company completed the acquisition of 7Hugs Labs S.A.S. ("7Hugs"). During fiscal 2020, the Company completed the acquisitions of Decawave Limited ("Decawave"), Custom MMIC Design Services, Inc. ("Custom MMIC"), Cavendish Kinetics Limited ("Cavendish"), and Active-Semi International, Inc. ("Active-Semi"). The goodwill resulting from these acquisitions is attributed to synergies and other benefits that are expected to be generated from these transactions.

The operating results of these companies, which were not material either individually or in the aggregate, have been included in the Company's consolidated financial statements as of the acquisition dates. As a result, pro forma results of operations for these acquisitions have not been presented.

7Hugs Labs S.A.S

On October 1, 2020, the Company acquired all of the outstanding equity interests of 7Hugs, a private developer of Ultra Wideband ("UWB") software and solutions, for a total purchase price of $48.7 million. The acquisition expands the Company's product offerings and is expected to support the ongoing development and adoption of UWB products and solutions.

The purchase price was allocated based on the estimated fair values of the assets acquired and liabilities assumed as follows (in thousands):


Intangible assets	$	40,100
Goodwill	21,840

Net tangible liabilities (1)	(5,652)
Deferred tax liability, net	(7,616)
Total purchase price	$	48,672

(1) Includes cash acquired of $1.0 million.

The intangible assets acquired consisted of developed technology. The fair value of the developed technology acquired was determined based on an income approach using the "relief from royalty method," which estimated the value by discounting the royalties avoided by acquiring the technology to present value as of the valuation date. The acquired developed technology asset is being amortized on a straight-line basis over the estimated useful life of 10 years.

The Company will continue to evaluate certain assets, liabilities and tax estimates over the measurement period (up to one year from the acquisition date). Goodwill recognized from the acquisition of 7Hugs has been assigned to the Mobile Products ("MP") segment and is not deductible for income tax purposes.

During fiscal 2021, the Company recorded acquisition and integration related costs associated with the acquisition of 7Hugs totaling $2.4 million in "Other operating expense" in the Consolidated Statement of Income.

Decawave Limited

On February 21, 2020, the Company acquired all of the outstanding equity interests of Decawave, a pioneer in UWB technology and provider of UWB solutions for mobile, automotive and Internet of Things ("IoT") applications, for a total purchase price of $372.2 million. The acquisition expands the Company's product and technology offerings that enable real-time, highly accurate and reliable local area precision-location services.

In addition to the purchase price consideration, the Company agreed to pay employees of Decawave total compensation of $23.1 million, primarily subject to their continued employment. This amount is being recognized as post-combination compensation expense over the period the employees provide the required services.

The purchase price, which was finalized during fiscal 2021, was allocated based on the estimated fair values of the assets acquired and liabilities assumed as follows (in thousands):


Intangible assets	$	246,060
Goodwill	145,581

Net tangible assets (1)	2,118
Deferred tax liability, net	(21,553)
Total purchase price	$	372,206

(1) Includes cash acquired of $5.0 million.

The more significant intangible assets acquired included developed technology of $235.0 million and customer relationships of $10.0 million.

The fair value of the Decawave developed technology acquired was determined based on an income approach using the "excess earnings method," which estimated the values of the intangible asset by discounting the future projected earnings of the asset to present value as of the valuation date. The acquired developed technology asset is being amortized on a straight-line basis over its estimated useful life of 7 years.

The fair value of Decawave customer relationships acquired was determined based on an income approach using the "with and without method," in which the value of the asset is determined by the difference in discounted cash flows of the profitability of the Company "with" the asset and the profitability of the Company "without" the asset. These customer relationships are being amortized on a straight-line basis over their estimated useful lives of 3 years.

Goodwill recognized from the acquisition of Decawave has been assigned to the MP segment and is not deductible for income tax purposes.

Custom MMIC Design Services, Inc.

On February 6, 2020, the Company acquired all of the outstanding equity interests of Custom MMIC, a supplier of high-performance gallium arsenide ("GaAs") and gallium nitride ("GaN") monolithic microwave integrated circuits ("MMICs") for defense, aerospace and commercial applications, for a total purchase price of $91.7 million. The acquisition expands the Company's millimeter wave ("mmWave") capabilities for product offerings in defense and commercial markets.

The purchase price was comprised of cash consideration of $86.0 million and contingent consideration of up to $10.0 million which is payable to the sellers in the first quarter of fiscal 2022 if certain revenue targets were achieved over a one-year period from the acquisition date. The estimated fair value of the contingent consideration was $5.7 million on the acquisition date and was remeasured to fair value each period with changes recognized in "Other operating expense." The fair value of the contingent consideration liability in included in "Accrued liabilities" and is equal to the maximum amount payable of $10.0 million as of April 3, 2021. See Note 7 for further information related to fair value measurement.

In addition to the purchase price consideration, an installment agreement was entered into for $15.5 million which is payable to certain key employees of Custom MMIC and is subject to their continued employment over a three-year period from the acquisition date. This amount is being recognized as post-combination compensation expense over the requisite service period.

The purchase price, which was finalized during fiscal 2021, was allocated based on the estimated fair values of the assets acquired and liabilities assumed as follows (in thousands):


Intangible assets	$	31,100
Goodwill	55,026
Net tangible assets (1)	5,616

Total purchase price	$	91,742

(1) Includes cash acquired of $2.3 million.

The more significant intangible assets acquired were customer relationships of $26.9 million. The fair value of Custom MMIC customer relationship intangibles acquired was determined based on an income approach using the "excess earnings method," which estimated the values of the intangible assets by discounting the future projected earnings of the asset to present value as of the valuation date. These customer relationships are being amortized on a straight-line basis over their estimated useful lives of 10 years.

Goodwill recognized from the acquisition of Custom MMIC has been assigned to the Infrastructure and Defense Products ("IDP") segment and is deductible for income tax purposes.

Cavendish Kinetics Limited

As of September 28, 2019, the Company had an investment in preferred shares in Cavendish, a private supplier of high-performance RF microelectromechanical system ("MEMS") technology for antenna tuning applications, with a carrying value of $59.4 million. The Company accounted for this investment as an equity investment without a readily determinable fair value using the measurement alternative in accordance with ASC 321, "Investments–Equity Securities."

On October 4, 2019, the Company acquired the remaining issued and outstanding capital of Cavendish for cash consideration of $198.4 million. The acquisition advances RF MEMS technology for applications across the Company's products, and the technology will be transitioned into high-volume manufacturing for mobile devices and other markets.

The purchase of the remaining equity interest in Cavendish was considered to be an acquisition achieved in stages, whereby the previously held equity interest was remeasured at its acquisition-date fair value. The Company determined that the fair value of its previously held equity investment was $102.4 million based on the purchase consideration exchanged to acquire the remaining issued and outstanding capital of Cavendish. This resulted in recognition of a gain of $43.0 million in fiscal 2020, which is recorded in "Other (expense) income, net" in the Consolidated Statement of Income.

The purchase price was calculated as follows (in thousands):


Cash consideration paid to Cavendish	$	198,385
Fair value of equity interest previously held by the Company	102,383

Total purchase price	$	300,768

The purchase price, which was finalized during fiscal 2021, was allocated based on the estimated fair values of the assets acquired and liabilities assumed as follows (in thousands):


Intangible assets	$	204,350
Goodwill	102,893

Net tangible liabilities (1)	(111)
Deferred tax liability, net	(6,364)
Total purchase price	$	300,768

(1) Includes cash acquired of $1.8 million.

The most significant intangible asset acquired was developed technology of $204.0 million. The fair value of the Cavendish developed technology acquired was determined based on an income approach using the "excess earnings method," which estimated the value of the intangible asset by discounting the future projected earnings of the asset to present value as of the valuation date. This developed technology is being amortized on a straight-line basis over its estimated useful life of 9 years.

Goodwill recognized from the acquisition of Cavendish has been assigned to the MP segment and is not deductible for income tax purposes.

Active-Semi International, Inc.

On May 6, 2019, the Company acquired all of the outstanding equity interests of Active-Semi, a private fabless supplier of programmable analog power management solutions, for a total purchase price of $307.9 million. The acquisition expanded the Company's product offerings in power management markets.

The purchase price, which was finalized during fiscal 2021, was allocated based on the estimated fair values of the assets acquired and liabilities assumed as follows (in thousands):


Intangible assets	$	158,400
Goodwill	130,913

Net tangible assets (1)	22,902
Deferred tax liability, net	(4,321)
Total purchase price	$	307,894

(1) Includes cash acquired of $10.0 million.

The more significant intangible assets acquired included developed technology of $76.7 million, customer relationships of $40.9 million and IPRD of $40.6 million.

The fair values of the Active-Semi developed technology and IPRD acquired were determined based on an income approach using the "excess earnings method," which estimated the values of the intangible assets by discounting the future projected earnings of the asset to present value as of the valuation date. The acquired developed technology assets are being amortized on a straight-line basis over their estimated useful lives of 5 to 9 years.

During fiscal 2020, $31.0 million of IPRD assets were completed, transferred to finite-lived intangible assets, and are being amortized over their estimated useful lives of 5 to 7 years. The remaining IPRD of $9.6 million is expected to be completed during fiscal 2022 with remaining costs to complete of less than $1.5 million.

The fair value of Active-Semi customer relationships acquired was determined based on an income approach using the "with and without method," in which the value of the asset is determined by the difference in discounted cash flows of the profitability of the Company "with" the asset and the profitability of the Company "without" the asset. These customer relationships are being amortized on a straight-line basis over their estimated useful lives of 5 years.

Goodwill recognized from the acquisition of Active-Semi has been assigned to the IDP segment and is not deductible for income tax purposes.

During fiscal years 2021 and 2020, the Company recorded post-combination compensation expense and other acquisition and integration related costs associated with the acquisition of Active-Semi of $0.8 million and $25.3 million, respectively, in "Other operating expense" in the Consolidated Statements of Income. During fiscal 2020, the Company also recorded $4.2 million of acquisition and integration related costs in "Cost of goods sold" in the Consolidated Statement of Income.

Goodwill and Intangible Assets

12 Months Ended

Apr. 03, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND INTANGIBLE ASSETS

The changes in the carrying amount of goodwill for fiscal 2021 are as follows (in thousands):


	Mobile Products		Infrastructure and Defense Products		Total
Balance as of March 28, 2020 (1)	$	2,005,432	$	608,842	$	2,614,274
Goodwill resulting from 7Hugs acquisition (Note 5)	21,840		—		21,840
Measurement period adjustments from prior acquisitions	(2,074)		(517)		(2,591)
Effect of changes in foreign currency exchange rates	9,185		—		9,185
Balance as of April 3, 2021 (1)	$	2,034,383	$	608,325	$	2,642,708

(1) The Company’s goodwill balance is presented net of accumulated impairment losses and write-offs of $621.6 million.

The following summarizes information regarding the gross carrying amounts and accumulated amortization of intangible assets (in thousands):


	April 3, 2021				March 28, 2020
	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Developed technology	$	1,295,113	$	750,044	$	1,331,262	$	652,411
Customer relationships	459,052		403,407		464,015		346,799
Technology licenses	2,368		2,076		3,272		2,327
Backlog	1,600		1,600		1,600		267
Trade names	1,090		636		1,224		283

IPRD	9,695		N/A		9,606		N/A

Total (1)	$	1,768,918	$	1,157,763	$	1,810,979	$	1,002,087

(1) Amounts include the impact of foreign currency translation.

Total intangible assets amortization expense was $252.9 million, $247.3 million and $454.5 million in fiscal years 2021, 2020 and 2019, respectively.

The following table provides the Company's estimated amortization expense for intangible assets based on current amortization periods for the periods indicated (in thousands):


Fiscal Year	Estimated Amortization Expense
2022	$	122,000
2023	106,000
2024	94,000
2025	79,000
2026	73,000

Investments and Fair Value Measurements

12 Months Ended

Apr. 03, 2021

Investments and Fair Value Measurements [Abstract]

INVESTMENTS AND FAIR VALUE MEASUREMENTS

INVESTMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS

Equity Method Investments

The Company invests in limited partnerships which are accounted for using the equity method. The carrying amounts of these investments as of April 3, 2021 and March 28, 2020 were $29.8 million and $14.2 million, respectively, and are classified as "Long-term investments" in the Consolidated Balance Sheets. During fiscal 2021, the Company recorded $21.5 million of income based on its share of the limited partnerships' earnings in "Other (expense) income, net" in the Consolidated Statement of Income. During fiscal 2021, the Company received cash distributions of $5.9 million from one of these investments. The distributions were recognized as a reduction to the carrying value of the investment, the majority of which represented a return of investment in cash flows from investing activities.

Equity Investments Without a Readily Determinable Fair Value

During fiscal 2020, the Company recorded an impairment of $18.3 million on an equity investment without a readily determinable fair value based on recent observable price changes present at the time. During fiscal 2021, the Company recorded an additional impairment of $2.8 million to fully impair this investment. These amounts are recorded in "Other (expense) income, net" in the Consolidated Statements of Income.

Fair Value of Financial Instruments

The Company's financial assets and liabilities measured at fair value on a recurring basis as determined using the levels of inputs within the fair value hierarchy are as follows (in thousands):


		Total		Quoted Prices In Active Markets For Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
April 3, 2021



	Marketable equity securities	$	3,802	$	3,802	$	—	$	—








	Invested funds in deferred compensation plan (1)	32,824		32,824		—		—


	Contingent earn-out liability (2)	(10,000)		—		—		(10,000)


March 28, 2020



	Marketable equity securities	$	459	$	459	$	—	$	—







	Invested funds in deferred compensation plan (1)	19,398		19,398		—		—


	Contingent earn-out liability (2)	(5,700)		—		—		(5,700)

(1) Invested funds under the Company's non-qualified deferred compensation plan are held in a rabbi trust and consist of mutual funds. The fair value of the mutual funds is calculated using the net asset value per share as determined by quoted active market prices of the underlying investments. See Note 10 for further information on the Company's non-qualified deferred compensation plan.

(2) The Company recorded a contingent earn-out liability in conjunction with the Custom MMIC acquisition. The fair value of this liability is estimated using an option pricing model and is remeasured to fair value each period with changes in fair value reported in "Other operating expense" in the Consolidated Statements of Income. As of April 3, 2021, the fair value of the contingent consideration liability was equal to the maximum amount payable of $10.0 million.

Leases

12 Months Ended

Apr. 03, 2021

Leases [Abstract]

Leases

LEASES

Operating Leases

The Company leases certain of its corporate, manufacturing and other facilities from multiple third-party real estate developers. The Company also leases various machinery and office equipment. These operating leases expire at various dates through 2036, and some of these leases have renewal options, with the longest ranging up to two, ten-year periods.

Operating leases are classified as follows (in thousands):


	April 3, 2021		March 28, 2020
Other non-current assets	$	62,925	$	65,107

Other current liabilities	$	15,068	$	15,917
Other long-term liabilities	$	53,172	$	58,077

Details of operating leases are as follows (in thousands):


	Fiscal Year
	2021			2020
Operating lease expense	$	17,382		$	15,184
Short-term lease expense	$	7,062		$	6,878
Variable lease expense	$	3,972		$	3,098

Cash paid for amounts included in measurement of lease liabilities:
Operating cash flows from operating leases	$	18,697		$	16,504

Operating lease assets obtained in exchange for new lease liabilities	$	12,899		$	13,201

Weighted-average remaining lease term (years)	7.9			7.8
Weighted-average discount rate	3.82		%	4.06		%

The aggregate future lease payments for operating leases as of April 3, 2021 are as follows (in thousands):


2022	$	17,194
2023	12,608
2024	9,823
2025	7,715
2026	7,603
Thereafter	23,900
Total lease payments	78,843
Less imputed interest	(10,603)
Present value of lease liabilities	$	68,240

In fiscal 2018, the Company entered into a lease for a facility in Beijing, China that will allow the Company to consolidate several leased facilities as well as provide additional manufacturing space. The lease term is expected to commence in fiscal 2022 and therefore, is not recorded on the Consolidated Balance Sheets as of April 3, 2021 and March 28, 2020. The lease has an initial term of five years and includes multiple renewal options, with the maximum lease term not to exceed 30 years. Upon lease commencement, $12.5 million of right-of-use assets and lease liabilities is expected to be recognized by the Company.

Debt

Jul. 16, 2018

Debt Disclosure [Abstract]

DEBT

LONG-TERM DEBT

Debt as of April 3, 2021 and March 28, 2020 is as follows (in thousands):


	April 3, 2021		March 28, 2020
Term loan	$	197,500	$	100,000
7.00% senior notes due 2025	—		23,404
5.50% senior notes due 2026	—		900,000
4.375% senior notes due 2029	850,000		550,000
3.375% senior notes due 2031	700,000		—
Finance leases	1,617		2,252
Unamortized premium and issuance costs, net	(1,475)		(1,532)
Less current portion of long-term debt	(5,092)		(6,893)
Total long-term debt	$	1,742,550	$	1,567,231

Credit Agreement

On September 29, 2020, the Company and certain of its U.S. subsidiaries (the “Guarantors”) entered into a five-year unsecured senior credit facility pursuant to a credit agreement (the “2020 Credit Agreement”) with Bank of America, N.A. acting as administrative agent (the “Administrative Agent”) and a syndicate of lenders. The 2020 Credit Agreement amended and restated the previous credit agreement dated as of December 5, 2017 (the “2017 Credit Agreement”). The 2020 Credit Agreement includes a senior term loan (the “2020 Term Loan”) of up to $200.0 million and a senior revolving line of credit (the “Revolving Facility”) of up to $300.0 million (collectively the “Credit Facility”).

During fiscal 2021, the Company made principal payments totaling $2.5 million on the term loan under the 2017 Credit Agreement (the “2017 Term Loan”). On the closing date of the 2020 Credit Agreement, the Company repaid the remaining principal balance of $97.5 million on the 2017 Term Loan and concurrently drew $200.0 million under the 2020 Term Loan.

During fiscal 2021, the Company made principal payments totaling $2.5 million on the 2020 Term Loan. Interest paid on the 2017 Term Loan and 2020 Term Loan during fiscal years 2021 and 2020 was $2.1 million and $2.4 million, respectively.

Pursuant to the 2020 Credit Agreement, the Company may request one or more additional tranches of term loans or increases to the Revolving Facility, up to an aggregate of $500.0 million and subject to securing additional funding commitments from the existing or new lenders. The Revolving Facility includes a $25.0 million sublimit for the issuance of standby letters of credit and a $10.0 million sublimit for swing line loans. The Credit Facility is available to finance working capital, capital expenditures and other general corporate purposes. Outstanding amounts are due in full on the maturity date of September 29, 2025, subject to scheduled amortization of the 2020 Term Loan principal prior to the maturity date as set forth in the 2020 Credit Agreement. During fiscal 2021, there were no borrowings under the Revolving Facility.

At the Company’s option, loans under the 2020 Credit Agreement will bear interest at (i) the Applicable Rate (as defined in the 2020 Credit Agreement) plus the Eurodollar Rate (as defined in the 2020 Credit Agreement) or (ii) the Applicable Rate plus a rate equal to the highest of (a) the federal funds rate plus 0.50%, (b) the prime rate as set by the Administrative Agent, and (c) the Eurodollar Rate plus 1.0% (the “Base Rate”). All swing line loans will bear interest at a rate equal to the Applicable Rate plus the Base Rate. The Eurodollar Rate is the rate per annum equal to the reserve adjusted London Interbank Offered Rate (or a comparable or successor rate), for dollar deposits for interest periods of one, two, three or six months, as selected by the Company. The Applicable Rate for Eurodollar Rate loans ranges from 1.000% per annum to 1.250% per annum, and the Applicable Rate for Base Rate loans ranges from 0.000% per annum to 0.250% per annum. Undrawn amounts under the Credit Facility are subject to a commitment fee ranging from 0.150% to 0.200%. Interest for Eurodollar Rate loans is payable at the end of each applicable interest period or at three-month intervals if such interest period exceeds three months. Interest for Base Rate loans is payable quarterly in arrears.

The 2020 Credit Agreement contains various conditions, covenants and representations with which the Company must be in compliance in order to borrow funds and to avoid an event of default. As of April 3, 2021, the Company was in compliance with these covenants.

The annual maturities of the Term Loan as of April 3, 2021 are as follows (in thousands):


Fiscal Year	Maturities
2022	$	5,000
2023	7,500
2024	7,500
2025	10,000
2026	167,500
	$	197,500

Senior Notes due 2025

On December 1, 2020, the Company redeemed the remaining $23.4 million principal amount of its 7.00% senior notes due December 1, 2025 (the “2025 Notes”) using cash on hand, at a redemption price equal to 103.50% of the principal amount, plus accrued and unpaid interest. In connection with the redemption, the Company recognized a loss on debt extinguishment of $1.0 million as "Other (expense) income, net" in the Consolidated Statement of Income. The loss on debt extinguishment consisted of a $0.8 million redemption premium and a $0.2 million write-off of the unamortized portion of the debt issuance costs.

Interest paid on the 2025 Notes during fiscal years 2021, 2020 and 2019 was $1.6 million, $1.6 million and $29.1 million, respectively.

Senior Notes due 2026

In fiscal years 2019 and 2018, the Company issued a total of $900.0 million aggregate principal amount of its 5.50% senior notes due July 15, 2026 (the "2026 Notes").

On October 16, 2020, the Company redeemed all of the 2026 Notes at a redemption price equal to 106.363% of the $900.0 million principal amount, plus accrued and unpaid interest. The 2026 Notes were redeemed using proceeds from the issuance of the 2031 Notes (as defined below) combined with cash on hand plus borrowings under the 2020 Term Loan. In connection with the redemption, the Company recognized a loss on debt extinguishment of $61.0 million as "Other (expense) income, net" in the Consolidated Statement of Income. The loss on debt extinguishment consisted of a $57.3 million redemption premium and a $3.7 million net write-off of unamortized debt issuance costs and bond premium. The primary purpose of the redemption was to reduce future interest expense.

Interest paid on the 2026 Notes during fiscal years 2021, 2020 and 2019 was $37.3 million, $49.5 million and $17.2 million, respectively.

Senior Notes due 2029

On September 30, 2019, the Company issued $350.0 million aggregate principal amount of its 4.375% senior notes due 2029 (the “Initial 2029 Notes”). On December 20, 2019 and June 11, 2020, the Company issued an additional $200.0 million and $300.0 million, respectively, aggregate principal amount of such notes (together, the “Additional 2029 Notes” and collectively with the Initial 2029 Notes, the “2029 Notes”). The 2029 Notes will mature on October 15, 2029, unless earlier redeemed in accordance with their terms. The 2029 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors.

The Initial 2029 Notes were issued pursuant to an indenture, dated as of September 30, 2019, by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee, and the Additional 2029 Notes were issued pursuant to supplemental indentures, dated as of December 20, 2019 and June 11, 2020 (such indenture and supplemental indentures, collectively, the “2019 Indenture”). The 2019 Indenture contains customary events of default, including payment default, failure to provide certain notices thereunder and certain provisions related to bankruptcy events and also contains customary negative covenants.

At any time prior to October 15, 2024, the Company may redeem all or part of the 2029 Notes, at a redemption price equal to 100% of their principal amount, plus a “make whole” premium as of the redemption date, and accrued and unpaid interest. In addition, at any time prior to October 15, 2024, the Company may redeem up to 35% of the original aggregate principal amount of the 2029 Notes with the proceeds of one or more equity offerings, at a redemption price equal to 104.375%, plus accrued and unpaid interest. Furthermore, at any time on or after October 15, 2024, the Company may redeem the 2029 Notes, in whole or in part, at the redemption prices specified in the 2019 Indenture, plus accrued and unpaid interest.

Interest is payable on the 2029 Notes on April 15 and October 15 of each year. Interest paid on the 2029 Notes during fiscal 2021 was $31.6 million.

Senior Notes due 2031

On September 29, 2020, the Company issued $700.0 million aggregate principal amount of its 3.375% senior notes due 2031 (the “2031 Notes”). The 2031 Notes will mature on April 1, 2031, unless earlier redeemed in accordance with their terms. The 2031 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors.

The 2031 Notes were issued pursuant to an indenture, dated as of September 29, 2020, by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee (the “2020 Indenture”). The 2020 Indenture contains customary events of default, including payment default, failure to provide certain notices thereunder and certain provisions related to bankruptcy events and also contains customary negative covenants.

At any time prior to April 1, 2026, the Company may redeem all or part of the 2031 Notes, at a redemption price equal to 100% of their principal amount, plus a “make whole” premium as of the redemption date, and accrued and unpaid interest. In addition, at any time prior to April 1, 2026, the Company may redeem up to 40% of the original aggregate principal amount of the 2031 Notes with the proceeds of one or more equity offerings, at a redemption price equal to 103.375%, plus accrued and unpaid interest. Furthermore, at any time on or after April 1, 2026, the Company may redeem the 2031 Notes, in whole or in part, at the redemption prices specified in the 2020 Indenture, plus accrued and unpaid interest.

The 2031 Notes have not been and will not be registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state securities laws, and may not be offered or sold in the United States absent an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws.

Interest is payable on the 2031 Notes on April 1 and October 1 of each year. Interest paid on the 2031 Notes during fiscal 2021 was $11.9 million.

Fair Value of Long-Term Debt

The Company's debt is carried at amortized cost and is measured at fair value quarterly for disclosure purposes. The estimated fair value of the 2029 Notes and the 2031 Notes as of April 3, 2021 was $905.3 million and $689.5 million, respectively (compared to a carrying value of $850.0 million and $700.0 million, respectively). The estimated fair value of the 2025 Notes, the 2026 Notes and the 2029 Notes as of March 28, 2020 was $23.9 million, $962.8 million, and $489.5 million, respectively (compared to a carrying value of $23.4 million, $900.0 million, and $550.0 million, respectively). The Company considers its debt to be Level 2 in the fair value hierarchy. Fair values are estimated based on quoted market prices for identical or similar instruments. The 2029 Notes and the 2031 Notes currently trade – and the 2025 Notes and the 2026 Notes previously traded – over the counter and their fair values were estimated based upon the value of their last trade at the end of the period.

The 2020 Term Loan carries a variable interest rate set at current market rates, and as such, the fair value of the 2020 Term Loan approximated book value as of April 3, 2021.

Interest Expense

During fiscal 2021, the Company recognized $79.3 million of interest expense primarily related to the 2026 Notes, the 2029 Notes and the 2031 Notes, which was partially offset by $4.1 million of interest capitalized to property and

equipment. During fiscal 2020, the Company recognized $66.0 million of interest expense primarily related to the 2026 Notes and the 2029 Notes, which was partially offset by $5.6 million of interest capitalized to property and equipment. During fiscal 2019, the Company recognized $52.8 million of interest expense primarily related to the senior notes due December 1, 2023 (which were fully retired during fiscal 2019), the 2025 Notes and the 2026 Notes, which was partially offset by $8.8 million of interest capitalized to property and equipment.

Retirement Benefit Plans	12 Months Ended
Retirement Benefit Plans	Apr. 03, 2021
Retirement Benefits [Abstract]
RETIREMENT BENEFIT PLANS	RETIREMENT BENEFIT PLANS Defined Contribution Plans The Company offers tax-beneficial retirement contribution plans to eligible employees in the U.S. and certain other countries. Eligible employees in certain countries outside of the U.S. are eligible to participate in stakeholder, group or national pension plans with differing eligibility and contributory requirements based on local and national regulations. U.S. employees are eligible to participate in the Company's fully qualified 401(k) plan 30 days after their date of hire. An employee may contribute and invest pretax and/or Roth dollars into the 401(k) plan up to the maximum legal limits (as defined by Federal regulations). Employer contributions to the 401(k) plan are made at the discretion of the Company’s Board of Directors. Employees are immediately vested in their own contributions as well as employer matching contributions. In total, the Company contributed $15.6 million, $14.4 million and $14.0 million to its domestic and foreign defined contribution plans during fiscal years 2021, 2020 and 2019, respectively. Defined Benefit Pension Plans The Company maintains two qualified defined benefit pension plans for its subsidiaries located in Germany. One of the plans is funded through a self-paid reinsurance program with assets valued at $3.8 million and $3.6 million as of April 3, 2021 and March 28, 2020, respectively (included in "Other non-current assets" in the Consolidated Balance Sheets). The pension benefit obligations of both plans were $14.0 million and $12.3 million as of April 3, 2021 and March 28, 2020, respectively, which is included in "Accrued liabilities" and "Other long-term liabilities" in the Consolidated Balance Sheets. The benefit obligations for the plans are calculated annually by an independent actuary and require the use of significant judgement including assumptions based on local economic conditions. The net periodic benefit costs were approximately $0.6 million, $0.6 million and $0.5 million for fiscal years 2021, 2020 and 2019, respectively. Non-Qualified Deferred Compensation Plan Certain employees and members of the Board of Directors are eligible to participate in the Company's Non-Qualified Deferred Compensation Plan ("NQDC Plan"). The NQDC Plan provides eligible participants the opportunity to defer and invest a specified percentage of their cash compensation. The NQDC Plan is a non-qualified plan that is maintained in a rabbi trust, which restricts the Company's use and access to the assets held, but is subject to the claims of the Company's creditors in the event that the Company becomes insolvent. The amount of compensation to be deferred by each participant is based on their own elections and is adjusted for any investment changes that the participant directs. This plan does not provide for employer contributions. The deferred compensation obligation and the fair value of the investments held in the rabbi trust were $32.8 million and $19.4 million as of April 3, 2021 and March 28, 2020, respectively. The current portion of the deferred compensation obligation and fair value of the assets held in the rabbi trust were $1.2 million and $0.9 million as of April 3, 2021 and March 28, 2020, respectively, and are included in "Other current assets" and "Accrued liabilities" in the Consolidated Balance Sheets. The non-current portion of the deferred compensation obligation and fair value of the assets held in the rabbi trust were $31.6 million and $18.5 million as of April 3, 2021 and March 28, 2020, respectively, and are included in "Other non-current assets" and "Other long-term liabilities" in the Consolidated Balance Sheets.

- Definition

The entire disclosure for retirement benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 55
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section S99
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(i)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (o)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (p)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 70
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-URI http://asc.fasb.org/topic&trid=2235017

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(03)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (q)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(1)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iii)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (l)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(2)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

+ Details

Commitments and Contingent Liabilities	12 Months Ended
Commitments and Contingent Liabilities	Apr. 03, 2021
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENT LIABILITIES	COMMITMENTS AND CONTINGENT LIABILITIES Purchase Commitments The Company's purchase commitments total approximately $419.2 million, a substantial majority of which will be due within the next 12 months. Purchase commitments include payments due for materials and manufacturing services and commitments for the purchase of property and equipment. Lease Commitments See Note 8 for disclosures related to lease commitments. Legal Matters The Company accrues a liability for legal contingencies when it believes that it is both probable that a liability has been incurred and that it can reasonably estimate the amount of the loss. The Company reviews these accruals and adjusts them to reflect ongoing negotiations, settlements, rulings, advice of legal counsel and other relevant information. To the extent new information is obtained and the Company's views on the probable outcomes of claims, suits, assessments, investigations or legal proceedings change, changes in the Company's accrued liabilities would be recorded in the period in which such determination is made. The Company is involved in various legal proceedings and claims that have arisen in the ordinary course of its business that have not been fully adjudicated. The aggregate range of reasonably possible losses in excess of accrued liabilities, if any, associated with these unresolved legal actions is not material. In some cases, the Company cannot reasonably estimate a range of loss because there is insufficient information regarding the matter. However, the Company believes there is no more than a remote chance that any liability arising from these matters would be material. Although it is not possible to predict with certainty the outcome of these unresolved legal actions, it is the opinion of management that these actions will not individually or in the aggregate have a material adverse effect on the Company’s consolidated financial position or results of operations.

Restructuring

12 Months Ended

Apr. 03, 2021

Restructuring and Related Activities [Abstract]

RESTRUCTURING

During fiscal years 2021, 2020 and 2019, the Company recorded restructuring related charges totaling approximately $2.7 million, $47.9 million and $50.7 million, respectively, related primarily to (1) fiscal 2019 actions to reduce operating expenses and improve manufacturing cost structure, (2) fiscal 2018 actions to improve operating efficiencies, and (3) actions resulting from the Business Combination.

During fiscal 2019, the Company initiated restructuring actions to reduce operating expenses and improve its manufacturing cost structure, including the phased closure of a wafer fabrication facility in Florida and idling production at a wafer fabrication facility in Texas. As a result of these restructuring actions, the Company has recorded cumulative restructuring related charges totaling approximately $93.4 million as of the end of fiscal 2021, including accelerated depreciation (to reflect changes in estimated useful lives of certain property and equipment), impairment charges (to adjust the carrying value of certain property and equipment to reflect its fair value), employee termination benefits and other exit costs.

The fair value of the real property was derived based upon a market approach with substantial input from market participants, including brokers, investors, developers and appraisers. The fair value of the personal property was determined using a market approach based upon quoted market prices from auction data for comparable assets. Factors such as age, condition, capacity and manufacturer were considered to adjust the auction price and determine an orderly liquidation value of the personal property assets. The significant inputs related to valuing these assets are classified as Level 2 in the fair value measurement hierarchy.

The following table summarizes the restructuring charges resulting from the 2019 restructuring event (in thousands):


	Fiscal 2021
	Cost of Goods Sold		Other Operating Expense		Total
One-time employee termination benefits	$	—	$	161	$	161
Contract termination and other associated costs	—		1,189		1,189

Total	$	—	$	1,350	$	1,350

	Fiscal 2020
	Cost of Goods Sold		Other Operating Expense		Total
One-time employee termination benefits	$	—	$	6,013	$	6,013
Contract termination and other associated costs	8,365		6,666		15,031
Accelerated depreciation	26,061		—		26,061
Total	$	34,426	$	12,679	$	47,105

	Fiscal 2019
	Cost of Goods Sold		Other Operating Expense		Total
One-time employee termination benefits	$	—	$	7,655	$	7,655

Asset impairment and accelerated depreciation	21,346		15,901		37,247
Total	$	21,346	$	23,556	$	44,902

The Company expects to record additional expenses of less than $0.1 million for employee termination benefits and other exit costs as a result of these actions.

The Company has entered into other individually immaterial restructuring plans. During fiscal years 2021, 2020 and 2019, the Company's restructuring charges related to these plans were $1.4 million, $0.8 million and $5.8 million, respectively.

The following table summarizes the activity related to the Company's restructuring liabilities for fiscal years 2020 and 2021 (in thousands):


	One-Time Employee Termination Benefits		Accelerated Depreciation		Contract Termination and Other Associated Costs		Total
Accrued restructuring balance as of March 30, 2019	$	6,988	$	—	$	1,626	$	8,614
Costs incurred and charged to expense	6,289		26,061		15,519		47,869
Transfer to right-of-use asset	—		—		(1,248)		(1,248)
Cash payments	(11,549)		—		(7,262)		(18,811)
Non-cash activity	—		(26,061)		(8,365)		(34,426)
Accrued restructuring balance as of March 28, 2020	$	1,728	$	—	$	270	$	1,998
Costs incurred and charged to expense	1,254		—		1,468		2,722
Cash payments	(2,206)		—		(1,409)		(3,615)
Non-cash activity	—		—		(167)		(167)
Accrued restructuring balance as of April 3, 2021	$	776	$	—	$	162	$	938

Income Taxes

12 Months Ended

Apr. 03, 2021

Income Tax Disclosure [Abstract]

INCOME TAXES

Income (loss) before income taxes consists of the following components (in thousands):


	Fiscal Year
	2021		2020		2019
United States	$	125,362	$	(226,005)	$	(297,975)
Foreign	682,018		621,094		389,767
Total	$	807,380	$	395,089	$	91,792

The components of the income tax provision are as follows (in thousands):


	Fiscal Year
	2021		2020		2019
Current (expense) benefit:
Federal	$	(11,043)	$	(6,705)	$	17,222
State	(140)		(93)		209
Foreign	(80,722)		(65,065)		(46,267)
	(91,905)		(71,863)		(28,836)
Deferred benefit (expense):
Federal	$	(35,545)	$	7,826	$	55,833
State	(3,771)		4,603		946
Foreign	57,452		(1,330)		13,390
	18,136		11,099		70,169
Total	$	(73,769)	$	(60,764)	$	41,333

A reconciliation of the provision for income taxes to income tax expense computed by applying the statutory federal income tax rate to pre-tax income (loss) for fiscal years 2021, 2020 and 2019 is as follows (dollars in thousands):


	Fiscal Year
	2021				2020				2019
	Amount		Percentage		Amount		Percentage		Amount		Percentage
Income tax expense at statutory federal rate	$	(169,550)	21.0	%	$	(82,969)	21.0	%	$	(19,276)	21.0	%
(Increase) decrease resulting from:
State (expense)/benefit, net of federal impact	(743)		0.1		2,605		(0.7)		710		(0.8)
Tax credits	92,532		(11.5)		64,017		(16.2)		69,856		(76.1)

Effect of changes in income tax rate applied to net deferred tax assets (1)	22,286		(2.8)		(2,269)		0.6		12,972		(14.1)
Foreign tax rate difference	85,851		(10.6)		75,247		(19.0)		41,672		(45.4)
Foreign permanent differences and related items	9,026		(1.1)		(5,446)		1.4		6,825		(7.4)
Change in valuation allowance	(1,232)		0.2		6,438		(1.6)		2,353		(2.6)

Expiration of state attributes	(1,656)		0.2		(5,165)		1.3		—		—
Stock-based compensation	9,545		(1.2)		(1,707)		0.4		(7,694)		8.4
Tax reserve adjustments	(9,979)		1.2		(13,973)		3.5		5,213		(5.7)
U.S. tax on foreign earnings, including GILTI & FDII (2)	(100,830)		12.5		(81,916)		20.8		(76,215)		83.0
U.S. Transitional Repatriation Tax	—		—		—		—		1,897		(2.1)
Intra-entity transfer	—		—		—		—		3,935		(4.3)

Permanent reinvestment assertion	(8,488)		1.1		(6,814)		1.7		—		—
Acquisition related adjustments	(919)		0.1		(7,257)		1.8		—		—
Other income tax (expense) benefit	388		(0.1)		(1,555)		0.4		(915)		1.1
	$	(73,769)	9.1	%	$	(60,764)	15.4	%	$	41,333	(45.0)	%

(1) In fiscal 2021, the Company completed the restructuring of the Cavendish intellectual property. A portion of this transaction is deductible in future periods at a rate higher than the applicable fiscal 2021 tax rate in Singapore. As a result, the Company recognized an income tax benefit of $22.1 million due to the favorable rate differential associated with this transaction. In fiscal 2019, the Company completed its analysis of the impact of the Tax Cuts and Jobs Act in accordance with Staff Accounting Bulletin No. 118 and recognized a $15.1 million tax benefit due to an increase in U.S. deferred tax assets.

(2) The Global Intangible Low-Taxed Income ("GILTI") and Foreign-Derived Intangible Income (“FDII”) provisions became effective for the Company in fiscal 2019, at which time the Company elected to treat taxes due on future GILTI inclusions in U.S. taxable income as current-period expense (the "period cost method").

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the basis used for income tax purposes. The deferred income tax assets and liabilities are measured in each taxing jurisdiction using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.

Significant components of the Company’s net deferred income taxes are as follows (in thousands):


	April 3, 2021		March 28, 2020
Deferred income tax assets:
Inventory reserve	$	9,632	$	10,114

Equity compensation	14,444		18,817
Net operating loss carry-forwards	24,474		71,928
Research and other credits	106,825		106,958
Employee benefits	19,357		12,606
Lease liabilities	15,947		16,456
Other deferred assets	8,662		3,559

Total deferred income tax assets	199,341		240,438
Valuation allowance	(36,512)		(35,280)
Total deferred income tax assets, net of valuation allowance	$	162,829	$	205,158

Deferred income tax liabilities:
Amortization and purchase accounting basis difference	$	(25,553)	$	(107,517)
Accumulated depreciation/basis difference	(59,756)		(59,356)
Accrued tax on unremitted foreign earnings	(21,747)		(15,521)
Deferred intercompany revenue (1)	(22,284)		—
Right-of-use assets	(14,663)		(14,400)

Other deferred liabilities	(1,681)		(1,955)
Total deferred income tax liabilities	(145,684)		(198,749)
Net deferred income tax asset	$	17,145	$	6,409

Amounts included in the Consolidated Balance Sheets:


Other non-current assets	$	59,056	$	45,754
Other long-term liabilities	(41,911)		(39,345)

Net deferred income tax asset	$	17,145	$	6,409

(1) In fiscal 2021, the Company completed the intercompany restructuring of the Cavendish intellectual property. Due to this transaction, a portion of revenue recognized by the intercompany seller is taxable in future periods and a corresponding deferred tax liability has been recorded.

The Company has recorded a valuation allowance against certain U.S. and foreign deferred tax assets as of April 3, 2021 and March 28, 2020. These valuation allowances were established based upon management's opinion that it is more likely than not (a likelihood of more than 50 percent) that the benefit of these deferred tax assets may not be realized.

The valuation allowance against deferred tax assets increased by approximately $1.2 million in fiscal 2021. The increase was comprised of a $2.1 million increase in the valuation allowance against certain domestic deferred tax assets for net operating losses and credits and a $0.9 million decrease for the valuation allowance against deferred tax assets for net operating losses at foreign subsidiaries. At the end of fiscal 2021, a $2.9 million valuation allowance remained against deferred assets at foreign subsidiaries and a $33.6 million valuation allowance remained against domestic deferred tax assets.

The valuation allowance against deferred tax assets decreased by $5.2 million in fiscal 2020. The decrease was comprised of a $7.9 million decrease in the valuation allowance against state deferred tax assets for net operating losses and tax credits and a $2.7 million increase for the valuation allowance against deferred tax assets for net operating losses at foreign subsidiaries. At the end of fiscal 2020, a $3.8 million valuation allowance remained against deferred tax assets at foreign subsidiaries and a $31.5 million valuation allowance remained against state deferred tax assets.

The valuation allowance against deferred tax assets decreased by $2.4 million in fiscal 2019. The decrease was comprised of a $1.5 million decrease in the valuation allowance against state deferred tax assets for net operating losses and tax credits, a $0.9 million decrease for the valuation allowance against deferred tax assets for net operating losses at foreign subsidiaries. At the end of fiscal 2019, a $1.1 million valuation allowance remained against deferred tax assets at foreign subsidiaries and a $39.3 million valuation allowance remained against state deferred tax assets.

As of April 3, 2021, the Company had federal loss carryovers of approximately $28.5 million that expire in fiscal years 2022 to 2041 if unused and state losses of approximately $139.9 million that expire in fiscal years 2022 to 2041 if unused. Federal research credits of $150.7 million, and state credits of $65.0 million expire in fiscal years 2030 to 2041 and 2022 to 2041, respectively. The Company had foreign losses of $115.8 million, which expire in fiscal years 2022 to 2031 if unused. Included in the amounts above are $22.1 million of foreign losses and $0.5 million of tax credits related to acquisitions in the current year. The utilization of acquired domestic assets is subject to certain annual limitations as required under Section 382 of the Internal Revenue Code of 1986, as amended (the "Code") and similar state income tax provisions.

The Company has continued to expand its operations and increase its investments in numerous international jurisdictions. These activities expose the Company to taxation in multiple foreign jurisdictions. As a result, management has concluded that it is not permanently reinvested on certain earnings of its foreign subsidiaries which have been subject to U.S. federal taxation. The remainder of the Company's untaxed foreign earnings and historic investments will continue to be permanently reinvested to fund working capital requirements and operations abroad. It is not practical to estimate the additional tax that would be incurred, if any, if the remainder of the permanently reinvested earnings were repatriated.

The Company has foreign subsidiaries with tax holiday agreements in Singapore and Costa Rica. These tax holiday agreements have varying rates and expire in December 2021 and December 2027, respectively. Incentives from these countries are subject to the Company meeting certain employment and investment requirements. Relative to the statutory tax rate, income tax expense decreased by $74.3 million (an impact of approximately $0.65 and $0.64 per basic and diluted share, respectively) in fiscal 2021 and $62.9 million (an impact of approximately $0.54 and $0.53 per basic and diluted share, respectively) in fiscal 2020 as a result of these agreements.

The Company’s gross unrecognized tax benefits totaled $134.1 million as of April 3, 2021, $119.2 million as of March 28, 2020, and $103.2 million as of March 30, 2019. Of these amounts, $128.7 million (net of federal benefit of state taxes), $114.8 million (net of federal benefit of state taxes) and $99.1 million (net of federal benefit of state taxes) as of April 3, 2021, March 28, 2020, and March 30, 2019, respectively, represent the amounts of unrecognized tax benefits that, if recognized, would impact the effective tax rate in each of the fiscal years.

The Company’s gross unrecognized tax benefits increased from $119.2 million as of March 28, 2020 to $134.1 million as of April 3, 2021, primarily due to increases related to current year tax positions, the effect of provision-to-return adjustments on prior year positions, and increases related to business combinations recognized as part of purchase accounting.

A reconciliation of fiscal 2019 through fiscal 2021 beginning and ending amount of gross unrecognized tax benefits is as follows (in thousands):


	Fiscal Year
	2021		2020		2019
Beginning balance	$	119,222	$	103,178	$	122,823
Additions based on positions related to current year	10,048		10,357		7,193
Additions for tax positions in prior years	6,240		6,484		8,369
Reductions for tax positions in prior years	(348)		(69)		(24,932)
Expiration of statute of limitations	(1,094)		(728)		(6,972)
Settlements	—		—		(3,303)
Ending balance	$	134,068	$	119,222	$	103,178

It is the Company’s policy to recognize interest and penalties related to uncertain tax positions as a component of income tax expense. During fiscal years 2021, 2020 and 2019, the Company recognized $0.8 million, $0.7 million and $(0.2) million, respectively, of interest and penalties related to uncertain tax positions. Accrued interest and penalties related to unrecognized tax benefits totaled $6.2 million, $5.4 million and $4.4 million as of April 3, 2021, March 28, 2020 and March 30, 2019, respectively.

The unrecognized tax benefits of $134.1 million and accrued interest and penalties of $6.2 million at the end of fiscal 2021 are recorded on the Consolidated Balance Sheet as a $21.2 million other long-term liability, with the balance reducing the carrying value of the gross deferred tax assets.

The Company currently believes it is reasonably possible that $2.2 million of gross unrecognized tax benefits, and $5.3 million of associated accrued interest and penalties will be recognized for positions taken in prior years within the next 12 months due to the expiration of statute of limitations. It is not reasonably possible to estimate other amounts by which unrecognized tax benefits may increase or decrease within the next 12 months due to uncertainties regarding the timing of examinations and the amount of settlements that may be paid, if any, to tax authorities.

Income taxes payable of $86.7 million and $50.8 million as of April 3, 2021 and March 28, 2020, respectively, are included in "Other current liabilities" in the Consolidated Balance Sheets. Income taxes receivable of $3.5 million and $5.4 million as of April 3, 2021 and March 28, 2020, respectively, are included in “Other current assets” in the Consolidated Balance Sheets. Long-term income taxes payable of $5.4 million and $5.6 million as of April 3, 2021 and March 28, 2020, respectively, which relates to the Transitional Repatriation Tax that the Company has elected to pay over eight years, is included in "Other long-term liabilities" in the Consolidated Balance Sheets.

Qorvo files a consolidated U.S. federal income tax return, as well as separate and combined income tax returns in numerous state and international jurisdictions. Qorvo’s fiscal 2018 U.S. federal and state tax returns and subsequent tax years remain open for examination, as well as all attributes brought forward into those years. The Company is also subject to examination by various international tax authorities. The tax years subject to examination vary by jurisdiction.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References + Details

Net Income (Loss) Per Share

12 Months Ended

Apr. 03, 2021

Earnings Per Share [Abstract]

NET INCOME (LOSS) PER SHARE

NET INCOME PER SHARE

The following table sets forth the computation of basic and diluted net income per share (in thousands, except per share data):


	Fiscal Year
	2021		2020		2019
Numerator:
Numerator for basic and diluted net income per share — net income available to common stockholders	$	733,611	$	334,325	$	133,125
Denominator:
Denominator for basic net income per share — weighted average shares	114,034		117,007		124,534
Effect of dilutive securities:
Stock-based awards	1,982		2,286		2,822
Denominator for diluted net income per share — adjusted weighted average shares and assumed conversions	116,016		119,293		127,356
Basic net income per share	$	6.43	$	2.86	$	1.07
Diluted net income per share	$	6.32	$	2.80	$	1.05

In the computation of diluted net income per share for fiscal years 2021, 2020 and 2019, approximately 0.1 million shares, 0.1 million shares and 0.3 million shares, respectively, were excluded because the effect of their inclusion would have been anti-dilutive.

Stock-Based Compensation

12 Months Ended

Apr. 03, 2021

Share-based Payment Arrangement [Abstract]

STOCK-BASED COMPENSATION

Summary of Stock Plans

2003 Stock Incentive Plan - RF Micro Devices, Inc.

The 2003 Stock Incentive Plan (the "2003 Plan") was approved by the Company's stockholders on July 22, 2003, and the Company was permitted to grant stock options and other types of equity incentive awards, such as stock appreciation rights, restricted stock awards, performance shares and performance units, under the 2003 Plan. No further awards can be granted under this plan.

2009 and 2012 Incentive Plans - TriQuint Semiconductor, Inc.

Effective upon the closing of the Business Combination, the Company assumed the TriQuint, Inc. 2009 Incentive Plan and TriQuint, Inc. 2012 Incentive Plan (the "TriQuint Incentive Plans"), originally adopted by TriQuint. The TriQuint Incentive Plans provided for the grant of stock options, restricted stock units, stock appreciation rights and other stock or cash awards to employees, officers, directors, consultants, agents, advisors and independent contractors of TriQuint and its subsidiaries and affiliates. The options granted thereunder were required to have an exercise price per share no less than 100% of the fair market value per share on the date of grant. The terms of each grant under the TriQuint Incentive Plans could not exceed ten years. No further awards can be granted under these plans.

2012 Stock Incentive Plan - Qorvo, Inc.

The Company currently grants stock options and restricted stock units to employees and directors under the 2012 Stock Incentive Plan (the "2012 Plan"), which was approved by the Company's stockholders on August 16, 2012, assumed by the Company in connection with the Business Combination and reapproved by the Company's stockholders on August 8, 2017 for purposes of Section 162(m) of the Code. Under the 2012 Plan, the Company is permitted to grant stock options and other types of equity incentive awards, such as stock appreciation rights, restricted stock awards, performance shares and performance units. The maximum number of shares issuable under the 2012 Plan may not exceed the sum of (a) 4.3 million shares, plus (b) any shares of common stock (i) remaining available for issuance as of the effective date of the 2012 Plan under the Company's prior plans and (ii) subject to an award granted under a prior plan, which awards are forfeited, canceled, terminated, expire or lapse for any reason. As of April 3, 2021, 2.7 million shares were available for issuance under the 2012 Plan. The aggregate number of shares subject to performance-based restricted stock units awarded for fiscal 2021 under the 2012 Plan was 0.2 million shares.

2013 Incentive Plan - Qorvo, Inc.

Effective upon the closing of the Business Combination, the Company assumed the TriQuint, Inc. 2013 Incentive Plan (the "2013 Incentive Plan"), originally adopted by TriQuint, allowing Qorvo to issue awards under this plan. The 2013 Incentive Plan replaces the TriQuint 2012 Incentive Plan and provides for the grant of stock options, restricted stock units, stock appreciation rights and other stock or cash awards to employees, officers, directors, consultants, agents, advisors and independent contractors of TriQuint and its subsidiaries and affiliates who were such prior to the Business Combination or who become employed by the Company or its affiliates after the closing of the Business Combination. Former employees, officers and directors of RFMD are not eligible for awards under the 2013 Incentive Plan. The options granted thereunder must have an exercise price per share no less than 100% of the fair market value per share on the date of grant. The terms of each grant under the 2013 Incentive Plan may not exceed ten years. As of April 3, 2021, 0.9 million shares were available for issuance under the 2013 Incentive Plan.

2015 Inducement Stock Plan - Qorvo, Inc.

The 2015 Inducement Stock Plan (the "2015 Inducement Plan") provides for the grant of equity awards to persons as a material inducement to become employees of the Company or its affiliates. The plan provides for the grant of stock options, restricted stock units, stock appreciation rights and other stock-based awards. The maximum number of shares issuable under the 2015 Inducement Plan may not exceed the sum of (a) 0.3 million shares, plus (b) any shares of common stock (i) remaining available for issuance as of the effective date of the 2015 Inducement Stock Plan under the TriQuint 2008 Inducement Award Plan and (ii) subject to an award granted under the TriQuint 2008 Inducement Award Plan, which awards are forfeited, canceled, terminated, expire or lapse for any reason. No awards were made under the 2015 Inducement Plan in fiscal years 2021, 2020 and 2019. As of April 3, 2021, 0.3 million shares were available for issuance under the 2015 Inducement Plan.

Employee Stock Purchase Plan - Qorvo, Inc.

Effective upon closing of the Business Combination, the Company assumed the TriQuint Employee Stock Purchase Plan ("ESPP"), which is intended to qualify as an "employee stock purchase plan" under Section 423 of the Code. All regular full-time employees of the Company (including officers) and all other employees who meet the eligibility requirements of the plan may participate in the ESPP. The ESPP provides eligible employees an opportunity to acquire the Company’s common stock at 85.0% of the lower of the closing price per share of the Company’s common stock on the first or last day of each six-month purchase period. At April 3, 2021, 3.3 million shares were available for future issuance under this plan. The Company makes no cash contributions to the ESPP, but bears the expenses of its administration. The Company issued 0.4 million shares under the ESPP in fiscal 2021 and 0.5 million shares in fiscal years 2020 and 2019.

For fiscal years 2021, 2020 and 2019, the primary stock-based awards and their general terms and conditions are as follows:

Restricted stock units granted by the Company in fiscal years 2021, 2020 and 2019 are either service-based or performance and service-based. Service-based restricted stock units generally vest over a four-year period from the grant date. Performance and service-based restricted stock units are earned based on Company performance of stated metrics during the fiscal year and, if earned, generally vest one-half when earned and the balance over two years. Restricted stock units granted to non-employee directors generally vest over a one-year period from the grant date. In fiscal 2021, each non-employee director was eligible to receive an annual grant of restricted stock units.

The options and restricted stock units granted to certain officers of the Company generally will, in the event of the officer's termination other than for cause and subject to the officer executing certain agreements in favor of the Company, continue to vest pursuant to the same vesting schedule as if the officer had remained an employee of the Company and, as a result, these awards are expensed at grant date. In fiscal 2021, stock-based compensation of $27.4 million was recognized upon the grant of 0.2 million restricted share units to certain officers of the Company.

Stock-Based Compensation

Under ASC 718, stock-based compensation cost is measured at the grant date, based on the estimated fair value of the award using an option pricing model for stock options (Black-Scholes) and market price for restricted stock units, and is recognized as expense over the employee's requisite service period. ASC 718 covers a wide range of stock-based compensation arrangements including stock options, restricted share plans, performance-based awards, share appreciation rights and employee stock purchase plans.

Total pre-tax stock-based compensation expense recognized in the Consolidated Statements of Income was $89.3 million, $76.0 million and $71.6 million, for fiscal years 2021, 2020 and 2019, respectively, net of expense capitalized into inventory.

A summary of activity with respect to stock options under the Company’s director and employee stock plans follows:


	Options (in thousands)	Weighted- Average Exercise Price		Weighted-Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding as of March 28, 2020	967	$	18.11

Granted	—	—
Exercised	(503)	$	18.88
Canceled	(6)	$	22.13
Forfeited	—	—
Outstanding as of April 3, 2021	458	$	17.21	1.64	$	80,465
Vested and expected to vest as of April 3, 2021	458	$	17.21	1.64	$	80,465
Options exercisable as of April 3, 2021	458	$	17.21	1.64	$	80,465

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value, based upon the Company’s closing stock price of $192.90 as of April 1, 2021 (the last Nasdaq trading day prior to the fiscal year end on April 3, 2021), that would have been received by the option holders had all option holders with in-the-money options exercised their options as of that date. As of April 3, 2021, there was no remaining unearned compensation cost related to unvested option awards.

The fair value of each option award is estimated on the date of grant using a Black-Scholes option-pricing model based on the expected volatility, dividend yield, term and risk-free interest rate. There were no options granted during fiscal years 2021, 2020 and 2019.

The total intrinsic value of options exercised during fiscal years 2021, 2020 and 2019 was $66.7 million, $65.1 million and $37.9 million, respectively.

Cash received from the exercise of stock options and from participation in the employee stock purchase plan (excluding accrued unremitted employee funds) was approximately $40.9 million for fiscal 2021 and is reflected in cash flows from financing activities in the Consolidated Statements of Cash Flows. The Company settles employee stock options with newly issued shares of the Company's common stock.

ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Based upon historical pre-vesting forfeiture experience, the Company assumed an annualized forfeiture rate of 1.4% for both stock options and restricted stock units.

A summary of activity with respect to restricted stock unit awards ("RSUs") under the Company’s director and employee stock plans follows:


	RSUs (in thousands)	Weighted-Average Grant-Date Fair Value
Balance at March 28, 2020	2,091	$	72.59
Granted	799	125.43

Vested	(965)	70.07
Forfeited	(66)	86.02
Balance at April 3, 2021	1,859	$	93.22

As of April 3, 2021, total remaining unearned compensation cost related to unvested restricted stock units was $103.7 million, which will be amortized over the weighted-average remaining service period of approximately 1.2 years.

The total intrinsic value of restricted stock units that vested during fiscal years 2021, 2020 and 2019 was $121.8 million, $67.7 million and $77.5 million, respectively, based upon the fair market value of the Company’s common stock on the vesting date.

Stockholders' Equity

12 Months Ended

Apr. 03, 2021

Equity [Abstract]

SHAREHOLDERS' EQUITY

STOCKHOLDERS’ EQUITY

Stock Repurchase

On October 31, 2019, the Company announced that its Board of Directors authorized a share repurchase program to repurchase up to $1.0 billion of the Company's outstanding common stock, which included approximately $117.0 million authorized under a prior program which was terminated concurrent with this authorization. Under this program, share repurchases were made in accordance with applicable securities laws on the open market or in privately negotiated transactions. The number and timing of shares repurchased depended on general market conditions, regulatory requirements, alternative investment opportunities and other considerations. The program did not require the Company to repurchase a minimum number of shares and did not have a fixed term.

The Company repurchased 3.6 million shares, 6.4 million shares and 9.1 million shares of its common stock during fiscal years 2021, 2020 and 2019, respectively, at an aggregate cost of $515.1 million, $515.1 million and $638.1 million, respectively. See Note 18 for further information about our share repurchase program.

Common Stock Reserved For Future Issuance

At April 3, 2021, the Company had reserved a total of approximately 9.4 million of its authorized 405.0 million shares of common stock for future issuance as follows (in thousands):


Outstanding stock options under formal directors’ and employees’ stock option plans			458
Possible future issuance under Company stock incentive plans			3,866
Employee stock purchase plan			3,257
Restricted stock-based units outstanding			1,859

Total shares reserved			9,440

Operating Segment and Geographical Information

12 Months Ended

Apr. 03, 2021

Segment Reporting [Abstract]

OPERATING SEGMENT AND GEOGRAPHIC INFORMATION

The Company's operating and reportable segments as of April 3, 2021 are MP and IDP based on the organizational structure and information reviewed by the Company's Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), and these segments are managed separately based on the end markets and applications they support. The CODM allocates resources and assesses the performance of each operating segment primarily based on operating income.

MP is a global supplier of cellular, UWB and Wi-Fi solutions for a variety of applications, including smartphones, wearables, laptops, tablets and IoT.

IDP is a global supplier of RF, system-on-a-chip and power management solutions for applications in wireless infrastructure, defense, Wi-Fi, smart home, automotive and IoT.

The "All other" category includes operating expenses such as stock-based compensation, amortization of intangible assets, acquisition and integration related costs, restructuring related charges, start-up costs, asset impairment and accelerated depreciation, (loss) gain on assets, and other miscellaneous corporate overhead expenses that the Company does not allocate to its reportable segments because these expenses are not included in the segment operating performance measures evaluated by the Company’s CODM. The CODM does not evaluate operating segments using discrete asset information. The Company’s operating segments do not record intercompany revenue. The Company does not allocate gains and losses from equity investments, interest and other (expense) income, or taxes to operating segments. Except as discussed above regarding the "All other" category, the Company’s accounting policies for segment reporting are the same as for the Company as a whole.

The following tables present details of the Company’s operating and reportable segments and a reconciliation of the "All other" category (in thousands):


	Fiscal Year
	2021		2020		2019
Revenue:
MP	$	2,856,813	$	2,397,740	$	2,197,660
IDP	1,158,494		841,401		892,665

Total revenue	$	4,015,307	$	3,239,141	$	3,090,325
Operating income (loss):
MP	$	1,008,171	$	715,514	$	558,990
IDP	283,507		145,295		267,304

All other	(385,051)		(437,593)		(609,828)
Operating income	$	906,627	$	423,216	$	216,466
Interest expense	$	(75,198)	$	(60,392)	$	(43,963)


Other (expense) income, net	(24,049)		32,265		(80,711)

Income before income taxes	$	807,380	$	395,089	$	91,792


	Fiscal Year
	2021		2020		2019
Reconciliation of "All other" category:
Stock-based compensation expense	$	(89,322)	$	(75,978)	$	(71,580)
Amortization of intangible assets	(252,137)		(246,563)		(453,515)


Acquisition and integration related costs	(32,946)		(61,891)		(8,522)
Restructuring related charges	(2,722)		(21,808)		(13,467)
Start-up costs	(1,731)		(712)		(18,035)
Asset impairment and accelerated depreciation	—		(27,118)		(37,246)
Other (including (loss) gain on assets and other miscellaneous corporate overhead)	(6,193)		(3,523)		(7,463)
Loss from operations for "All other"	$	(385,051)	$	(437,593)	$	(609,828)

The consolidated financial statements include revenue to customers by geographic region that are summarized as follows (in thousands):


	Fiscal Year
	2021		2020		2019
Revenue:
United States	$	1,631,110	$	1,468,358	$	1,379,528
China	1,579,017		1,106,679		1,094,061
Other Asia	363,523		340,400		271,797
Taiwan	248,708		169,337		188,745
Europe	192,949		154,367		156,194

Total Revenue	$	4,015,307	$	3,239,141	$	3,090,325

During the first quarter of fiscal 2020, the Company changed its presentation of net revenue based on the "sold to" address of the customer to the above presentation of net revenue based on the location of the customers' headquarters. The information above for fiscal 2019 has been reclassified to reflect this change. The Company believes that the disaggregation of revenue based on the location of the customers' headquarters is more representative of how its revenue and cash flows are impacted by geographically-sensitive changes in economic factors.

The consolidated financial statements include the following long-lived tangible asset amounts related to operations of the Company by geographic region (in thousands):


	April 3, 2021		March 28, 2020
Long-lived tangible assets:
United States	$	1,011,686	$	1,042,587
China	200,346		166,524
Other countries	53,999		50,092

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510

+ Details

Subsequent Events	12 Months Ended
Subsequent Events	Apr. 03, 2021
Subsequent Events [Abstract]
Subsequent Events	SUBSEQUENT EVENTS NextInput, Inc. Acquisition On April 5, 2021, the Company acquired all of the outstanding equity interests of NextInput, Inc., a leader in MEMS-based sensing solutions, for cash consideration of approximately $173.2 million. The acquisition expands the Company's offerings of MEMS-based products for mobile applications and provides comprehensive sensing solution opportunities for a broad range of applications in other markets. Share Repurchase Program On May 5, 2021, the Company announced that its Board of Directors authorized a new share repurchase program to repurchase up to $2.0 billion of the Company's outstanding common stock, which includes approximately $236.9 million authorized under the prior program terminated concurrent with the new authorization. Under this new program, share repurchases will be made in accordance with applicable securities laws on the open market or in privately negotiated transactions. The extent to which the Company repurchases its shares, the number of shares and the timing of any repurchases will depend on general market conditions, regulatory requirements, alternative investment opportunities and other considerations. The program does not require the Company to repurchase a minimum number of shares, does not have a fixed term, and may be modified, suspended or terminated at any time without prior notice.

The Company and Its Significant Accounting Policies (Policies)	12 Months Ended
	Apr. 03, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Principles of Consolidation and Basis of Presentation	Principles of Consolidation and Basis of PresentationThe consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Certain items in the fiscal years 2020 and 2019 financial statements have been reclassified to conform to the fiscal 2021 presentation.
Accounting Periods	Accounting PeriodsThe Company uses a 52- or 53-week fiscal year ending on the Saturday closest to March 31 of each year. The most recent three fiscal years ended on April 3, 2021, March 28, 2020 and March 30, 2019. Fiscal 2021 was a 53-week year and fiscal years 2020 and 2019 were 52-week years.
Use of Estimates	Use of EstimatesThe preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and the disclosure of contingent liabilities. The Company evaluates its estimates on an ongoing basis, including those related to revenue recognition, product warranty obligations, valuation of inventories, tax related contingencies, valuation of long-lived and intangible assets, other contingencies and litigation, among others. The Company generally bases its estimates on historical experience, expected future conditions and third-party evaluations. Accounting estimates require difficult and subjective judgments and actual results may differ from the Company’s estimates, particularly in light of the uncertainty relating to the impact of the COVID-19 pandemic. Certain accounting estimates that generally require consideration of expected future conditions were assessed by taking into account anticipated impacts from the COVID-19 pandemic as of April 3, 2021 and through the date of this Annual Report on Form 10-K using reasonably available information as of those dates.
Cash and Cash Equivalents	Cash and Cash EquivalentsCash and cash equivalents consist of demand deposit accounts, money market funds, and other temporary, highly liquid investments with original maturities of three months or less when purchased.
Investments	Investments Marketable equity securities consist of common stock in publicly-traded companies and are carried at fair value with both the realized and unrealized gains and losses reported in "Other (expense) income, net." Fair values of publicly-traded equity securities are determined using quoted prices in active markets. The marketable equity securities are classified as short-term based on their highly liquid nature and are recorded in "Other current assets" in the Consolidated Balance Sheets. The Company invests in limited partnerships which are accounted for using the equity method. These equity method investments are classified as "Long-term investments" in the Consolidated Balance Sheets. The Company records its share of the financial results of the limited partnerships in "Other (expense) income, net" in the Company's Consolidated Statements of Income. The Company also invests in privately held companies for which the fair value of the investment is not readily determinable. These equity investments without a readily determinable fair value are measured at cost less impairment, adjusted for any changes in observable prices, and are classified as "Long-term investments" in the Consolidated Balance Sheets. The Company assesses these investments for impairment on a quarterly basis and considers both qualitative and quantitative factors that may have a significant impact on the investee's fair value. Qualitative factors considered include the investee's financial condition and business outlook, market for technology and other relevant events and factors affecting the investee. Investments are impaired when their fair value is less than their carrying value.
Fair Value Measurement	Fair Value Measurement The Company measures and reports certain financial assets and liabilities on a recurring basis. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company categorizes its financial instruments carried at fair value into a three-level fair value hierarchy, based on the priority of inputs to the respective valuation technique. The three-level hierarchy for fair value measurement is described as follows: •Level 1 - includes instruments for which inputs are quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. •Level 2 - includes instruments for which the inputs are other than quoted prices that are observable for the asset or liability, either directly or indirectly, and fair value can be determined through the use of models or other valuation methodologies that do not require significant judgment since the inputs are corroborated by readily observable data. •Level 3 - includes instruments for which the valuations are based on inputs that are unobservable and significant to the overall fair value measurement. These inputs are supported by little or no market activity and reflect the use of significant management judgment. The Company also holds assets whose fair value is measured and recorded on a nonrecurring basis. These assets include equity method investments, equity investments without a readily determinable fair value, and certain non-financial assets, such as intangible assets and property and equipment. See Note 7 for further information on equity method investments and equity investments without a readily determinable fair value and Note 12 for further information on impairment of property and equipment. The carrying values of cash, cash equivalents and restricted cash, accounts receivable, accounts payable and other accrued liabilities approximate fair values because of the relatively short-term maturities of these instruments. See Note 9 for further disclosures related to the fair value of the Company's long-term debt.
Inventories	Inventories Inventories are stated at the lower of cost or net realizable value (cost is based on standard cost, which approximates actual average cost). Cost includes labor, materials and manufacturing overhead related to the purchase and production of inventories. Abnormal production levels are charged to "Cost of goods sold" in the period incurred rather than as a portion of inventory cost. The Company’s business is subject to the risk of technological and design changes. The Company evaluates inventory levels quarterly against demand forecasts on a material or product family basis to evaluate its overall inventory risk. Reserves are adjusted to reflect inventory values in excess of demand forecasts and management's analysis and assessment of overall inventory risk. In the event the Company sells inventory that had been covered by a specific inventory reserve, the sale is recorded at the actual selling price and the related cost of goods sold is recorded at the full inventory cost, net of the reserve.
Product Warranty	Product Warranty The Company generally sells products with a limited warranty on product quality. The Company accrues for known warranty issues if a loss is probable and can be reasonably estimated and accrues for estimated incurred but unidentified issues based on historical activity. The accrual and the related expense for known product warranty issues were not significant during the periods presented. Due to product testing and the short time typically between product shipment and the detection and correction of product failures and the historical rate of losses, the accrual and related expense for estimated incurred but unidentified issues was also not significant during the periods presented.
Property and Equipment	Property and Equipment Property and equipment are stated at cost, less accumulated depreciation. Depreciation of property and equipment is computed using the straight-line method over the estimated useful lives of the assets, ranging from one year to 39 years. The Company capitalizes interest on borrowings related to eligible capital expenditures. Capitalized interest is added to the cost of qualified assets and depreciated together with that asset cost. The Company’s assets acquired under finance leases and leasehold improvements are amortized over the lesser of the asset life or lease term (which is reasonably assured) and included in depreciation. The Company records capital-related government grants earned as a reduction to property and equipment and depreciates such grants over the estimated useful lives of the associated assets. The Company periodically evaluates the period over which it expects to recover the economic value of the Company’s property and equipment, considering factors such as changes in machinery and equipment technology, the ability to re-use equipment across generations of process technology and historical usage trends. If the Company determines that the useful lives of its assets are shorter or longer than originally estimated, the rate of depreciation is adjusted to reflect the revised useful lives of the assets. The Company assesses property and equipment for impairment when events or changes in circumstances indicate that the carrying amount of its assets may not be recoverable. Factors that are considered in deciding when to perform an impairment review include an adverse change in the use of the Company’s assets or an expectation that the assets will be sold or otherwise disposed. The Company assesses the recoverability of the assets held and used by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining estimated useful lives against their respective carrying amounts. Assets identified as "held for sale" are recorded at the lesser of their carrying value or their fair market value less costs to sell. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets.
Lessee, Leases [Policy Text Block]	Leases The Company determines that a contract contains a lease at lease inception if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. In evaluating whether the right to control an identified asset exists, the Company assesses whether it has the right to direct the use of the identified asset and obtain substantially all of the economic benefit from the use of the identified asset. Right-of-use assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. The Company uses its estimated incremental borrowing rate in determining the present value of lease payments considering the term of the lease, which is derived from information available at the lease commencement date. The lease term includes renewal options when it is reasonably certain that the option will be exercised and excludes termination options. To the extent that the Company's agreements have variable lease payments, the Company includes variable lease payments that depend on an index or a rate and excludes those that depend on facts or circumstances occurring after the commencement date, other than the passage of time. The Company elected the practical expedient not to separate lease and non-lease components for substantially all of its classes of leases and to account for the combined lease and non-lease components as a single lease component. In addition, the Company made an accounting policy election to exclude leases with an initial term of 12 months or less from the balance sheet.
Business Combinations Policy [Policy Text Block]	Business Acquisitions The Company allocates the fair value of the purchase price to the assets acquired and liabilities assumed based on their estimated fair value. The excess of the purchase price over the fair values of the identifiable assets and liabilities is recorded to goodwill. Goodwill is assigned to the Company's reporting unit that is expected to benefit from the synergies of the business combination. A number of assumptions, estimates and judgments are used in determining the fair value of acquired assets and liabilities, particularly with respect to the intangible assets acquired. The valuation of intangible assets requires the Company to use valuation techniques such as the income approach. The income approach includes management’s estimation of future cash flows (including expected revenue growth rates and profitability), the underlying product or technology life cycles and the discount rates applied to future cash flows. Judgment is also required in estimating the fair values of deferred tax assets and liabilities, uncertain tax positions and tax-related valuation allowances, which are initially estimated as of the acquisition date, as well as inventory, property and equipment, pre-existing liabilities or legal claims, deferred revenue and contingent consideration, each as may be applicable. While the Company uses its best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date as well as contingent consideration, where applicable, the Company’s estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. After the measurement period, any purchase price adjustments are recognized in the Consolidated Statements of Income.
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]	Goodwill The Company performs an annual impairment assessment of goodwill at the reporting unit level on the first day of the fourth quarter in each fiscal year, or more frequently if indicators of potential impairment exist. In accordance with Accounting Standards Codification ("ASC") 350, the Company may assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value, including goodwill. In performing a qualitative assessment, the Company considers (i) its overall historical and projected future operating results, (ii) if there was a significant decline in the Company’s stock price for a sustained period, (iii) if there was a significant change in the Company’s market capitalization relative to its net book value, and (iv) if there was a prolonged or more significant slowdown in the worldwide economy of the semiconductor industry, as well as other relevant events and factors affecting the reporting unit. If the Company assesses these qualitative factors and concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, or if the Company decides not to perform a qualitative assessment, then a quantitative impairment test is performed. In fiscal years 2021 and 2019, the Company completed qualitative assessments and concluded that based on the relevant facts and circumstances, it was more likely than not that each reporting unit’s fair value exceeded its related carrying value and no further impairment testing was required. In fiscal 2020, the Company performed a quantitative impairment test. The Company’s quantitative impairment test considered both the income approach and the market approach to estimate each reporting unit’s fair value. The resulting fair value, based on the income and market approaches, was then compared to the carrying value to determine if impairment is necessary. As a result of the quantitative analysis performed, it was determined that the fair value of each of the Company’s reporting units substantially exceeded their carrying values.
Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]	Identified Intangible Assets The Company amortizes finite-lived intangible assets (including developed technology, customer relationships, technology licenses, backlog and trade names) over their estimated useful life. In-process research and development ("IPRD") assets represent the fair value of incomplete research and development ("R&D") projects that had not reached technological feasibility as of the date of the acquisition and are initially not subject to amortization. Upon completion of development, IPRD assets are transferred to developed technology and are amortized over their useful lives. The asset balances relating to abandoned projects are impaired and expensed to R&D. The Company performs a quarterly review of significant intangible assets to determine whether facts and circumstances (including external factors such as industry and economic trends and internal factors such as changes in the Company’s business strategy and forecasts) indicate that the carrying amount of the assets may not be recoverable. If such facts and circumstances exist, the Company assesses the recoverability of identified intangible assets by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining lives against their respective carrying amounts. Impairments, if any, are based on the excess of the carrying amounts over the fair value of those assets and occur in the period in which the impairment determination was made.
Accrued Liabilities	Accrued LiabilitiesThe "Accrued liabilities" balance as of April 3, 2021 and March 28, 2020, includes accrued compensation and benefits of $135.4 million and $126.1 million, respectively, and interest payable of $17.5 million and $22.8 million, respectively.
Revenue Recognition	Revenue Recognition The Company generates revenue primarily from the sale of semiconductor products, either directly to a customer or to a distributor, or at completion of a consignment process. Revenue is recognized when control of the promised goods or services is transferred to the Company's customers, in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. A majority of the Company's revenue is recognized at a point in time, either on shipment or delivery of the product, depending on individual customer terms and conditions. Revenue from sales to the Company’s distributors is recognized upon shipment of the product to the distributors (sell-in). Revenue is recognized from the Company’s consignment programs at a point in time when the products are pulled from consignment inventory by the customer. Revenue recognized for products and services over time is immaterial (less than 2% of overall revenue). The Company applies a five-step approach as defined in ASC 606, "Revenue from Contracts with Customers," in determining the amount and timing of revenue to be recognized: (1) identifying the contract with a customer; (2) identifying the performance obligations in the contract; (3) determining the transaction price; (4) allocating the transaction price to the performance obligations in the contract; and (5) recognizing revenue when the corresponding performance obligation is satisfied. Sales agreements are in place with certain customers and contain terms and conditions with respect to payment, delivery, warranty and supply, but typically do not require minimum purchase commitments. In the absence of a sales agreement, the Company’s standard terms and conditions apply. The Company considers a customer's purchase order, which is governed by a sales agreement or the Company’s standard terms and conditions, to be the contract with the customer. The Company’s pricing terms are negotiated independently, on a stand-alone basis. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which the Company expects to be entitled. Variable consideration in the form of rebate programs is offered to certain customers, including distributors, and represents less than 7% of net revenue. The Company determines variable consideration by estimating the most likely amount of consideration it expects to receive from the customer. The Company's terms and conditions do not give its customers a right of return associated with the original sale of its products. However, the Company may authorize sales returns under certain circumstances, which include courtesy returns and like-kind exchanges. The Company reduces revenue and records reserves for product returns and allowances, rebate programs and scrap allowance based on historical experience or specific identification depending on the contractual terms of the arrangement. The Company’s accounts receivable balance is from contracts with customers and represents the Company’s unconditional right to receive consideration from its customers. Payments are due upon completion of the performance obligation and subsequent invoicing. Substantially all payments are collected within the Company’s standard terms, which do not include any financing components. To date, there have been no material impairment losses on accounts receivable. Contract assets and contract liabilities recorded on the Consolidated Balance Sheets were immaterial as of April 3, 2021 and March 28, 2020. The Company invoices customers upon shipment and recognizes revenues in accordance with delivery terms. As of April 3, 2021, the Company had $87.5 million in remaining unsatisfied performance obligations with an original duration greater than one year, of which the majority is expected to be recognized as income over the next 12 months. The Company includes shipping charges billed to customers in "Revenue" and includes the related shipping costs in "Cost of goods sold" in the Consolidated Statements of Income. Taxes assessed by government authorities on revenue-producing transactions, including tariffs, value-added and excise taxes, are excluded from revenue in the Consolidated Statements of Income. The Company incurs commission expense that is incremental to obtaining contracts with customers. Sales commissions (which are recorded in the "Selling, general and administrative" expense line item in the Consolidated Statements of Income) are expensed when incurred because such commissions are not owed until the performance obligation is satisfied, which coincides with the end of the contract term, and therefore, no remaining period exists over which to amortize the commissions.
Research and Development	Research and Development The Company charges all R&D costs to expense as incurred.
Income Taxes	Income Taxes The Company accounts for income taxes under the liability method, which requires recognition of deferred tax assets and liabilities for the temporary differences between the financial reporting and tax basis of assets and liabilities and for tax carryforwards. Deferred tax assets and liabilities for each tax jurisdiction are measured using the enacted statutory tax rates in effect for the years in which the differences are expected to reverse. A valuation allowance is provided against deferred tax assets to the extent the Company determines it is more likely than not that some portion or all of its deferred tax assets will not be realized. A more likely than not recognition threshold is required to be met before the Company recognizes the benefit of an income tax position in its financial statements. The Company’s policy is to recognize accrued interest and penalties, if incurred, on any unrecognized tax benefits as a component of income tax expense. It is the Company’s current intent and policy to repatriate certain previously taxed earnings of foreign subsidiaries from outside the U.S. Accordingly, the Company recognizes a deferred tax liability for income taxes on certain unremitted foreign earnings of foreign subsidiaries. For earnings which remain permanently reinvested, it is not practical to estimate the additional tax that would be incurred, if any, if the permanently reinvested earnings were repatriated.
Stock-Based Compensation	Stock-Based Compensation Under ASC 718, "Compensation – Stock Compensation," stock-based compensation cost is measured at the grant date, based on the estimated fair value of the award using an option pricing model for stock options (Black-Scholes) and market price for restricted stock units, and is recognized as expense over the employee's requisite service period. As of April 3, 2021, total remaining unearned compensation cost related to unvested restricted stock units was $103.7 million, which will be amortized over the weighted-average remaining service period of approximately 1.2 years.
Foreign Currency Translation	Foreign Currency Translation The financial statements of foreign subsidiaries have been translated into U.S. dollars in accordance with ASC 830, "Foreign Currency Matters." The functional currency for most of the Company’s international operations is the U.S. dollar. The functional currency for the remainder of the Company’s foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rates on the balance sheet dates. Revenues and expenses are translated using the weighted average exchange rates throughout the year. Translation adjustments are shown separately as a component of "Accumulated other comprehensive income" within "Stockholders’ equity" in the Consolidated Balance Sheets. Foreign currency transaction gains or losses (transactions denominated in a currency other than the functional currency) are reported in "Other (expense) income, net" in the Consolidated Statements of Income.
Recent Accounting Pronouncements	Accounting Pronouncements Recently Adopted In June 2016, the Financial Accounting Standards Board issued Accounting Standards Update ("ASU") 2016-13, "Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments," which requires a current lifetime expected credit loss methodology to be used to measure impairments of accounts receivable and other financial assets. Using this methodology will result in earlier recognition of losses than under the previous incurred loss approach, which requires waiting to recognize a loss until it is probable of being incurred. The Company adopted this standard using the modified retrospective transition method, in the first quarter of fiscal 2021, which resulted in a cumulative-effect adjustment to retained earnings of less than $0.1 million. Under this new standard, the Company's trade receivables are now evaluated on a collective (pool) basis and aggregated on the basis of similar risk characteristics. These aggregated risk pools will be reassessed at each measurement date. A combination of factors is considered in determining the appropriate estimate of expected credit losses which include broad-based economic indicators as well as customers' financial strength, credit standing, payment history and any historical defaults. The adoption of this standard did not have a material impact on the Company's consolidated financial statements.

Operating Segment and Geographic Information Policies (Policies)	12 Months Ended
	Apr. 03, 2021
Segment Reporting [Abstract]
Segment Reporting, Policy [Policy Text Block]	The Company's operating and reportable segments as of April 3, 2021 are MP and IDP based on the organizational structure and information reviewed by the Company's Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), and these segments are managed separately based on the end markets and applications they support. The CODM allocates resources and assesses the performance of each operating segment primarily based on operating income.

- Definition

Disclosure of accounting policy for segment reporting.

+ References + Details

Inventories (Tables)

12 Months Ended

Apr. 03, 2021

Inventory Disclosure [Abstract]

Components of inventories

The components of inventories, net of reserves, are as follows (in thousands):


	April 3, 2021		March 28, 2020
Raw materials	$	134,959	$	112,671
Work in process	283,067		291,028
Finished goods	89,761		113,499
Total inventories	$	507,787	$	517,198

Property and Equipment (Tables)

12 Months Ended

Apr. 03, 2021

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment [Table Text Block]

The components of property and equipment are as follows (in thousands):


	April 3, 2021		March 28, 2020
Land	$	25,842	$	25,842
Building and leasehold improvements	411,180		404,075
Machinery and equipment	2,282,059		2,145,511


Construction in progress	108,563		99,172
Total property and equipment, gross	2,827,644		2,674,600
Less accumulated depreciation	(1,561,613)		(1,415,397)
Total property and equipment, net	$	1,266,031	$	1,259,203

Business Acquisitions Business Acquisitions (Tables)

Oct. 01, 2020

Feb. 21, 2020

Feb. 06, 2020

Oct. 04, 2019

May 06, 2019

Business Acquisitions [Abstract]

7Hugs Purchase Price Allocation

The purchase price was allocated based on the estimated fair values of the assets acquired and liabilities assumed as follows (in thousands):


Intangible assets	$	40,100
Goodwill	21,840

Net tangible liabilities (1)	(5,652)
Deferred tax liability, net	(7,616)
Total purchase price	$	48,672

(1) Includes cash acquired of $1.0 million.

Decawave Purchase Price Allocation [Table Text Block]

The purchase price, which was finalized during fiscal 2021, was allocated based on the estimated fair values of the assets acquired and liabilities assumed as follows (in thousands):


Intangible assets	$	246,060
Goodwill	145,581

Net tangible assets (1)	2,118
Deferred tax liability, net	(21,553)
Total purchase price	$	372,206

(1) Includes cash acquired of $5.0 million.

Custom MMIC Purchase Price Allocation [Table Text Block]

The purchase price, which was finalized during fiscal 2021, was allocated based on the estimated fair values of the assets acquired and liabilities assumed as follows (in thousands):


Intangible assets	$	31,100
Goodwill	55,026
Net tangible assets (1)	5,616

Total purchase price	$	91,742

(1) Includes cash acquired of $2.3 million.

Cavendish purchase price calculation

The purchase price was calculated as follows (in thousands):


Cash consideration paid to Cavendish	$	198,385
Fair value of equity interest previously held by the Company	102,383

Total purchase price	$	300,768

Cavendish Purchase Price Allocation [Table Text Block]

The purchase price, which was finalized during fiscal 2021, was allocated based on the estimated fair values of the assets acquired and liabilities assumed as follows (in thousands):


Intangible assets	$	204,350
Goodwill	102,893

Net tangible liabilities (1)	(111)
Deferred tax liability, net	(6,364)
Total purchase price	$	300,768

(1) Includes cash acquired of $1.8 million.

Active-Semi Purchase Price Allocation [Table Text Block]

The purchase price, which was finalized during fiscal 2021, was allocated based on the estimated fair values of the assets acquired and liabilities assumed as follows (in thousands):


Intangible assets	$	158,400
Goodwill	130,913

Net tangible assets (1)	22,902
Deferred tax liability, net	(4,321)
Total purchase price	$	307,894

(1) Includes cash acquired of $10.0 million.

Goodwill and Intangible Assets (Tables)

6 Months Ended

12 Months Ended

Oct. 03, 2020

Apr. 03, 2021

Indefinite-lived Intangible Assets [Line Items]

Schedule of Goodwill [Table Text Block]

The changes in the carrying amount of goodwill for fiscal 2021 are as follows (in thousands):


	Mobile Products		Infrastructure and Defense Products		Total
Balance as of March 28, 2020 (1)	$	2,005,432	$	608,842	$	2,614,274
Goodwill resulting from 7Hugs acquisition (Note 5)	21,840		—		21,840
Measurement period adjustments from prior acquisitions	(2,074)		(517)		(2,591)
Effect of changes in foreign currency exchange rates	9,185		—		9,185
Balance as of April 3, 2021 (1)	$	2,034,383	$	608,325	$	2,642,708

(1) The Company’s goodwill balance is presented net of accumulated impairment losses and write-offs of $621.6 million.

Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table Text Block]

The following summarizes information regarding the gross carrying amounts and accumulated amortization of intangible assets (in thousands):


	April 3, 2021				March 28, 2020
	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Developed technology	$	1,295,113	$	750,044	$	1,331,262	$	652,411
Customer relationships	459,052		403,407		464,015		346,799
Technology licenses	2,368		2,076		3,272		2,327
Backlog	1,600		1,600		1,600		267
Trade names	1,090		636		1,224		283

IPRD	9,695		N/A		9,606		N/A

Total (1)	$	1,768,918	$	1,157,763	$	1,810,979	$	1,002,087

(1) Amounts include the impact of foreign currency translation.

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

The following table provides the Company's estimated amortization expense for intangible assets based on current amortization periods for the periods indicated (in thousands):


Fiscal Year	Estimated Amortization Expense
2022	$	122,000
2023	106,000
2024	94,000
2025	79,000
2026	73,000

Investments and Fair Value Measurements (Tables)

12 Months Ended

Apr. 03, 2021

Schedule of available-for-sale debt securities

Fair value of the financial assets measured at fair value on a recurring basis

The Company's financial assets and liabilities measured at fair value on a recurring basis as determined using the levels of inputs within the fair value hierarchy are as follows (in thousands):


		Total		Quoted Prices In Active Markets For Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
April 3, 2021



	Marketable equity securities	$	3,802	$	3,802	$	—	$	—








	Invested funds in deferred compensation plan (1)	32,824		32,824		—		—


	Contingent earn-out liability (2)	(10,000)		—		—		(10,000)


March 28, 2020



	Marketable equity securities	$	459	$	459	$	—	$	—







	Invested funds in deferred compensation plan (1)	19,398		19,398		—		—


	Contingent earn-out liability (2)	(5,700)		—		—		(5,700)

Leases (Tables)

12 Months Ended

Apr. 03, 2021

Leases [Abstract]

Schedule of supplemental balance sheet information related to operating leases [Table Text Block]

Operating leases are classified as follows (in thousands):


	April 3, 2021		March 28, 2020
Other non-current assets	$	62,925	$	65,107

Other current liabilities	$	15,068	$	15,917
Other long-term liabilities	$	53,172	$	58,077

Schedule of lease costs, weighted-average remaining lease term and discount rate, and supplemental cash/non-cash information related to operating leases [Table Text Block]

Details of operating leases are as follows (in thousands):


	Fiscal Year
	2021			2020
Operating lease expense	$	17,382		$	15,184
Short-term lease expense	$	7,062		$	6,878
Variable lease expense	$	3,972		$	3,098

Cash paid for amounts included in measurement of lease liabilities:
Operating cash flows from operating leases	$	18,697		$	16,504

Operating lease assets obtained in exchange for new lease liabilities	$	12,899		$	13,201

Weighted-average remaining lease term (years)	7.9			7.8
Weighted-average discount rate	3.82		%	4.06		%

Lessee, Operating Lease, Liability, Maturity [Table Text Block]

The aggregate future lease payments for operating leases as of April 3, 2021 are as follows (in thousands):


2022	$	17,194
2023	12,608
2024	9,823
2025	7,715
2026	7,603
Thereafter	23,900
Total lease payments	78,843
Less imputed interest	(10,603)
Present value of lease liabilities	$	68,240

Debt (Tables)

12 Months Ended

Apr. 03, 2021

Debt Disclosure [Abstract]

Schedule of Long-term Debt Instruments [Table Text Block]

Debt as of April 3, 2021 and March 28, 2020 is as follows (in thousands):


	April 3, 2021		March 28, 2020
Term loan	$	197,500	$	100,000
7.00% senior notes due 2025	—		23,404
5.50% senior notes due 2026	—		900,000
4.375% senior notes due 2029	850,000		550,000
3.375% senior notes due 2031	700,000		—
Finance leases	1,617		2,252
Unamortized premium and issuance costs, net	(1,475)		(1,532)
Less current portion of long-term debt	(5,092)		(6,893)
Total long-term debt	$	1,742,550	$	1,567,231

Schedule of Maturities of Long-term Debt [Table Text Block]

The annual maturities of the Term Loan as of April 3, 2021 are as follows (in thousands):


Fiscal Year	Maturities
2022	$	5,000
2023	7,500
2024	7,500
2025	10,000
2026	167,500
	$	197,500

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

+ Details

Restructuring Tables (Tables)

12 Months Ended

Apr. 03, 2021

Restructuring and Related Activities [Abstract]

Restructuring and Related Costs [Table Text Block]

The following table summarizes the restructuring charges resulting from the 2019 restructuring event (in thousands):


	Fiscal 2021
	Cost of Goods Sold		Other Operating Expense		Total
One-time employee termination benefits	$	—	$	161	$	161
Contract termination and other associated costs	—		1,189		1,189

Total	$	—	$	1,350	$	1,350

	Fiscal 2020
	Cost of Goods Sold		Other Operating Expense		Total
One-time employee termination benefits	$	—	$	6,013	$	6,013
Contract termination and other associated costs	8,365		6,666		15,031
Accelerated depreciation	26,061		—		26,061
Total	$	34,426	$	12,679	$	47,105

	Fiscal 2019
	Cost of Goods Sold		Other Operating Expense		Total
One-time employee termination benefits	$	—	$	7,655	$	7,655

Asset impairment and accelerated depreciation	21,346		15,901		37,247
Total	$	21,346	$	23,556	$	44,902

The Company expects to record additional expenses of less than $0.1 million for employee termination benefits and other exit costs as a result of these actions.

Income Taxes (Tables)

12 Months Ended

Apr. 03, 2021

Income Tax Disclosure [Abstract]

Income before income taxes

Income (loss) before income taxes consists of the following components (in thousands):


	Fiscal Year
	2021		2020		2019
United States	$	125,362	$	(226,005)	$	(297,975)
Foreign	682,018		621,094		389,767
Total	$	807,380	$	395,089	$	91,792

Components of the income tax (provision) benefit

The components of the income tax provision are as follows (in thousands):


	Fiscal Year
	2021		2020		2019
Current (expense) benefit:
Federal	$	(11,043)	$	(6,705)	$	17,222
State	(140)		(93)		209
Foreign	(80,722)		(65,065)		(46,267)
	(91,905)		(71,863)		(28,836)
Deferred benefit (expense):
Federal	$	(35,545)	$	7,826	$	55,833
State	(3,771)		4,603		946
Foreign	57,452		(1,330)		13,390
	18,136		11,099		70,169
Total	$	(73,769)	$	(60,764)	$	41,333

Reconciliation of the (provision for) or benefit from income taxes to income tax(expense) or benefit computed by applying the statutory federal income tax rate to pre-tax income.


	Fiscal Year
	2021				2020				2019
	Amount		Percentage		Amount		Percentage		Amount		Percentage
Income tax expense at statutory federal rate	$	(169,550)	21.0	%	$	(82,969)	21.0	%	$	(19,276)	21.0	%
(Increase) decrease resulting from:
State (expense)/benefit, net of federal impact	(743)		0.1		2,605		(0.7)		710		(0.8)
Tax credits	92,532		(11.5)		64,017		(16.2)		69,856		(76.1)

Effect of changes in income tax rate applied to net deferred tax assets (1)	22,286		(2.8)		(2,269)		0.6		12,972		(14.1)
Foreign tax rate difference	85,851		(10.6)		75,247		(19.0)		41,672		(45.4)
Foreign permanent differences and related items	9,026		(1.1)		(5,446)		1.4		6,825		(7.4)
Change in valuation allowance	(1,232)		0.2		6,438		(1.6)		2,353		(2.6)

Expiration of state attributes	(1,656)		0.2		(5,165)		1.3		—		—
Stock-based compensation	9,545		(1.2)		(1,707)		0.4		(7,694)		8.4
Tax reserve adjustments	(9,979)		1.2		(13,973)		3.5		5,213		(5.7)
U.S. tax on foreign earnings, including GILTI & FDII (2)	(100,830)		12.5		(81,916)		20.8		(76,215)		83.0
U.S. Transitional Repatriation Tax	—		—		—		—		1,897		(2.1)
Intra-entity transfer	—		—		—		—		3,935		(4.3)

Permanent reinvestment assertion	(8,488)		1.1		(6,814)		1.7		—		—
Acquisition related adjustments	(919)		0.1		(7,257)		1.8		—		—
Other income tax (expense) benefit	388		(0.1)		(1,555)		0.4		(915)		1.1
	$	(73,769)	9.1	%	$	(60,764)	15.4	%	$	41,333	(45.0)	%

Significant components of net deferred income taxes

Significant components of the Company’s net deferred income taxes are as follows (in thousands):


	April 3, 2021		March 28, 2020
Deferred income tax assets:
Inventory reserve	$	9,632	$	10,114

Equity compensation	14,444		18,817
Net operating loss carry-forwards	24,474		71,928
Research and other credits	106,825		106,958
Employee benefits	19,357		12,606
Lease liabilities	15,947		16,456
Other deferred assets	8,662		3,559

Total deferred income tax assets	199,341		240,438
Valuation allowance	(36,512)		(35,280)
Total deferred income tax assets, net of valuation allowance	$	162,829	$	205,158

Deferred income tax liabilities:
Amortization and purchase accounting basis difference	$	(25,553)	$	(107,517)
Accumulated depreciation/basis difference	(59,756)		(59,356)
Accrued tax on unremitted foreign earnings	(21,747)		(15,521)
Deferred intercompany revenue (1)	(22,284)		—
Right-of-use assets	(14,663)		(14,400)

Other deferred liabilities	(1,681)		(1,955)
Total deferred income tax liabilities	(145,684)		(198,749)
Net deferred income tax asset	$	17,145	$	6,409

Amounts included in the Consolidated Balance Sheets:


Other non-current assets	$	59,056	$	45,754
Other long-term liabilities	(41,911)		(39,345)

Net deferred income tax asset	$	17,145	$	6,409

Reconciliation of gross unrecognized tax benefits

A reconciliation of fiscal 2019 through fiscal 2021 beginning and ending amount of gross unrecognized tax benefits is as follows (in thousands):


	Fiscal Year
	2021		2020		2019
Beginning balance	$	119,222	$	103,178	$	122,823
Additions based on positions related to current year	10,048		10,357		7,193
Additions for tax positions in prior years	6,240		6,484		8,369
Reductions for tax positions in prior years	(348)		(69)		(24,932)
Expiration of statute of limitations	(1,094)		(728)		(6,972)
Settlements	—		—		(3,303)
Ending balance	$	134,068	$	119,222	$	103,178

Net Income (Loss) Per Share (Tables)

12 Months Ended

Apr. 03, 2021

Earnings Per Share [Abstract]

Reconciliation of the numerators and denominators in the computation of basic and diluted net income (loss) per share

The following table sets forth the computation of basic and diluted net income per share (in thousands, except per share data):


	Fiscal Year
	2021		2020		2019
Numerator:
Numerator for basic and diluted net income per share — net income available to common stockholders	$	733,611	$	334,325	$	133,125
Denominator:
Denominator for basic net income per share — weighted average shares	114,034		117,007		124,534
Effect of dilutive securities:
Stock-based awards	1,982		2,286		2,822
Denominator for diluted net income per share — adjusted weighted average shares and assumed conversions	116,016		119,293		127,356
Basic net income per share	$	6.43	$	2.86	$	1.07
Diluted net income per share	$	6.32	$	2.80	$	1.05

Stock-Based Compensation (Tables)

6 Months Ended

12 Months Ended

Oct. 03, 2020

Apr. 03, 2021

Share-based Payment Arrangement [Abstract]

Summary of activity of the Company's director and employee stock option plans

A summary of activity with respect to stock options under the Company’s director and employee stock plans follows:


	Options (in thousands)	Weighted- Average Exercise Price		Weighted-Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding as of March 28, 2020	967	$	18.11

Granted	—	—
Exercised	(503)	$	18.88
Canceled	(6)	$	22.13
Forfeited	—	—
Outstanding as of April 3, 2021	458	$	17.21	1.64	$	80,465
Vested and expected to vest as of April 3, 2021	458	$	17.21	1.64	$	80,465
Options exercisable as of April 3, 2021	458	$	17.21	1.64	$	80,465

Restricted share plans


	RSUs (in thousands)	Weighted-Average Grant-Date Fair Value
Balance at March 28, 2020	2,091	$	72.59
Granted	799	125.43

Vested	(965)	70.07
Forfeited	(66)	86.02
Balance at April 3, 2021	1,859	$	93.22

Stockholders' Equity (Tables)

6 Months Ended

Oct. 03, 2020

Equity [Abstract]

Common stock reserved for future issuance

At April 3, 2021, the Company had reserved a total of approximately 9.4 million of its authorized 405.0 million shares of common stock for future issuance as follows (in thousands):


Outstanding stock options under formal directors’ and employees’ stock option plans			458
Possible future issuance under Company stock incentive plans			3,866
Employee stock purchase plan			3,257
Restricted stock-based units outstanding			1,859

Total shares reserved			9,440

Operating Segment and Geographical Information (Tables)

6 Months Ended

12 Months Ended

Oct. 03, 2020

Apr. 03, 2021

Segment Reporting [Abstract]

Summary of details of reportable segments

The following tables present details of the Company’s operating and reportable segments and a reconciliation of the "All other" category (in thousands):


	Fiscal Year
	2021		2020		2019
Revenue:
MP	$	2,856,813	$	2,397,740	$	2,197,660
IDP	1,158,494		841,401		892,665

Total revenue	$	4,015,307	$	3,239,141	$	3,090,325
Operating income (loss):
MP	$	1,008,171	$	715,514	$	558,990
IDP	283,507		145,295		267,304

All other	(385,051)		(437,593)		(609,828)
Operating income	$	906,627	$	423,216	$	216,466
Interest expense	$	(75,198)	$	(60,392)	$	(43,963)


Other (expense) income, net	(24,049)		32,265		(80,711)

Income before income taxes	$	807,380	$	395,089	$	91,792

Summary of reconciliation of All other category


	Fiscal Year
	2021		2020		2019
Reconciliation of "All other" category:
Stock-based compensation expense	$	(89,322)	$	(75,978)	$	(71,580)
Amortization of intangible assets	(252,137)		(246,563)		(453,515)


Acquisition and integration related costs	(32,946)		(61,891)		(8,522)
Restructuring related charges	(2,722)		(21,808)		(13,467)
Start-up costs	(1,731)		(712)		(18,035)
Asset impairment and accelerated depreciation	—		(27,118)		(37,246)
Other (including (loss) gain on assets and other miscellaneous corporate overhead)	(6,193)		(3,523)		(7,463)
Loss from operations for "All other"	$	(385,051)	$	(437,593)	$	(609,828)

Sales to customers by geographic region

The consolidated financial statements include revenue to customers by geographic region that are summarized as follows (in thousands):


	Fiscal Year
	2021		2020		2019
Revenue:
United States	$	1,631,110	$	1,468,358	$	1,379,528
China	1,579,017		1,106,679		1,094,061
Other Asia	363,523		340,400		271,797
Taiwan	248,708		169,337		188,745
Europe	192,949		154,367		156,194

Total Revenue	$	4,015,307	$	3,239,141	$	3,090,325

Long-lived assets by geographic region

The consolidated financial statements include the following long-lived tangible asset amounts related to operations of the Company by geographic region (in thousands):


	April 3, 2021		March 28, 2020
Long-lived tangible assets:
United States	$	1,011,686	$	1,042,587
China	200,346		166,524
Other countries	53,999		50,092

The Company and Its Significant Accounting Policies (Details) - USD ($)	12 Months Ended
	Apr. 03, 2021	Mar. 28, 2020	Mar. 30, 2019
The Company and Its Significant Accounting Policies [Line Items]
Revenue for product and services over time as a percent of total revenue	2.00%
Revenue, Remaining Performance Obligation, Amount	$ 87,500,000
Accrued compensation and benefits	135,400,000	$ 126,100,000
Interest Payable	$ 17,500,000	22,800,000
Rebates As Percentage Of Sales [Less Than]	7.00%
Cumulative-effect adoption of ASU 2016-13	$ (38,000)
Goodwill, Impairment Loss	$ 0	$ 0	$ 0
Minimum
The Company and Its Significant Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life	1 year
Maximum
The Company and Its Significant Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life	39 years
Retained Earnings
The Company and Its Significant Accounting Policies [Line Items]
Cumulative-effect adoption of ASU 2016-13	$ 100,000
Restricted Stock
The Company and Its Significant Accounting Policies [Line Items]
Total remaining unearned compensation cost related to nonvested restricted stock units and options	$ 103,700,000
Weighted-average remaining service period of unearned compensation costs related to nonvested restricted stock units and options	1 year 2 months 12 days

Concentrations of Credit Risk (Details)	12 Months Ended
Concentrations of Credit Risk (Details)	Apr. 03, 2021	Mar. 28, 2020	Mar. 30, 2019
Revenue from significant customers
Three largest accounts receivable balances percentage [Line Items]	58.00%	49.00%
Sales Revenue, Net \| Customer Concentration Risk \| Apple
Revenue from significant customers
Percentage	30.00%	33.00%	32.00%
Percentage	30.00%	33.00%	32.00%
Sales Revenue, Net \| Customer Concentration Risk \| Huawei
Revenue from significant customers
Percentage	5.00%	10.00%	15.00%
Percentage	5.00%	10.00%	15.00%

Inventories (Details) - USD ($) $ in Thousands	Apr. 03, 2021	Mar. 28, 2020
Components of inventories
Raw materials	$ 134,959	$ 112,671
Work in process	283,067	291,028
Finished goods	89,761	113,499
Total inventories	$ 507,787	$ 517,198

Property and Equipment (Details) - USD ($) $ in Thousands	Apr. 03, 2021	Mar. 28, 2020
Property, Plant and Equipment [Abstract]
Land	$ 25,842	$ 25,842
Building and leasehold improvements	411,180	404,075
Machinery and equipment	2,282,059	2,145,511
Construction in progress	108,563	99,172
Property, Plant and Equipment, Gross	2,827,644	2,674,600
Less accumulated depreciation	(1,561,613)	(1,415,397)
Property and equipment, net	$ 1,266,031	$ 1,259,203

Business Acquisitions (Details Textual) - USD ($) $ in Thousands						3 Months Ended	12 Months Ended
	Oct. 01, 2020	Feb. 21, 2020	Feb. 06, 2020	Oct. 04, 2019	May 06, 2019	Jan. 02, 2021	Apr. 03, 2021	Mar. 28, 2020	Mar. 30, 2019
Business Acquisition [Line Items]
Completed and transferred acquired in-process research and development during period							$ 31,000
Remaining research and development costs							1,500
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain							0	$ 43,008	$ 0
Goodwill, Acquired During Period							2,642,708	2,614,274
In-process research and development
Business Acquisition [Line Items]
IPRD							9,600	9,606
Custom MMIC [Member]
Business Acquisition [Line Items]
Payments to Acquire Businesses, Gross			$ 86,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents			2,300
Business Combination, Net Tangible Assets Acquired			(5,616)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			31,100
Goodwill, Acquired During Period			55,026
Business Combination, Contingent Consideration, Liability, Noncurrent			(5,700)
Business Combination, Consideration Transferred			91,742
Business Combination, Installment Agreement			15,500
Business Combination, Contingent Consideration, Liability, Current							10,000
Cavendish [Member]
Business Acquisition [Line Items]
Payments to Acquire Businesses, Gross				$ 198,385
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents				1,800
Business Combination, Net Tangible Assets Acquired				111
Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value				102,383
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill				204,350
Goodwill, Acquired During Period				102,893
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities				(6,364)
Business Combination, Consideration Transferred	$ 48,700			300,768
Active-Semi
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents					$ 10,000
Research and Development in Process					40,600
Business Combination, Net Tangible Assets Acquired					(22,902)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill					158,400
Goodwill, Acquired During Period					130,913
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities					(4,321)
Business Combination, Consideration Transferred					307,894
Decawave [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents		$ 5,000
Business Combination, Net Tangible Assets Acquired		(2,118)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill		246,060
Goodwill, Acquired During Period		145,581
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities		(21,553)
Business Combination, Consideration Transferred		372,206
Post-combination consideration		23,100
7Hugs
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents		1,000
Business Combination, Net Tangible Assets Acquired	5,652
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	40,100
Goodwill, Acquired During Period	21,840
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities	(7,616)
Business Combination, Consideration Transferred	$ 48,672
Developed Technology \| Custom MMIC [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			$ 26,900
Developed Technology \| Cavendish [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill				$ 204,000
Developed Technology \| Active-Semi
Business Acquisition [Line Items]
Finite-lived Intangible Assets Acquired					76,700
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life				9 years
Developed Technology \| Decawave [Member]
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life			7 years
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill		235,000
Developed Technology \| 7Hugs
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life			10 years
Customer Relationships \| Custom MMIC [Member]
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life			10 years
Customer Relationships \| Active-Semi
Business Acquisition [Line Items]
Finite-lived Intangible Assets Acquired					$ 40,900
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life					5 years
Customer Relationships \| Decawave [Member]
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life			3 years
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill		$ 10,000
Minimum \| Developed Technology \| Active-Semi
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life					5 years
Minimum \| In-process research and development \| Active-Semi
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life					5 years
Maximum \| Developed Technology \| Active-Semi
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life					9 years
Maximum \| In-process research and development \| Active-Semi
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life					7 years
Other Income [Member] \| Cavendish [Member]
Business Acquisition [Line Items]
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain						$ 43,000
Other Operating Income (Expense) [Member] \| Custom MMIC [Member]
Business Acquisition [Line Items]
Integration related costs							10,300	9,400
Other Operating Income (Expense) [Member] \| Cavendish [Member]
Business Acquisition [Line Items]
Integration related costs							700	3,800
Other Operating Income (Expense) [Member] \| Active-Semi
Business Acquisition [Line Items]
Integration related costs							800	25,300
Other Operating Income (Expense) [Member] \| Decawave [Member]
Business Acquisition [Line Items]
Post-combination consideration							11,300	12,400
Other Operating Income (Expense) [Member] \| 7Hugs
Business Acquisition [Line Items]
Integration related costs							2,400
Cost of Sales [Member] \| Active-Semi
Business Acquisition [Line Items]
Business Combination, Acquisition And Integration related costs							$ 4,200
Cavendish [Member]
Business Acquisition [Line Items]
Equity Securities without Readily Determinable Fair Value, Amount								$ 59,400

Goodwill and Intangible Assets (Details 1) - USD ($) $ in Thousands	12 Months Ended
	Apr. 03, 2021	Oct. 01, 2020	Mar. 28, 2020
Gross carrying amounts and amortization of intangibles
Accumulated Amortization	$ 1,157,763		$ 1,002,087
Goodwill, Foreign Currency Translation Gain (Loss)	9,185
Gross Carrying Amount	1,768,918		1,810,979
Goodwill, Acquired During Period	2,642,708		2,614,274
Goodwill, Period Increase (Decrease)	(2,591)
Technology licenses
Gross carrying amounts and amortization of intangibles
Gross Carrying Amount	2,368		3,272
Accumulated Amortization	2,076		2,327
Backlog [Member]
Gross carrying amounts and amortization of intangibles
Gross Carrying Amount	1,600
Accumulated Amortization	1,600		267
Customer Relationships
Gross carrying amounts and amortization of intangibles
Gross Carrying Amount	459,052		464,015
Accumulated Amortization	403,407		346,799
Developed Technology
Gross carrying amounts and amortization of intangibles
Gross Carrying Amount	1,295,113		1,331,262
Accumulated Amortization	750,044		652,411
Trade Names
Gross carrying amounts and amortization of intangibles
Gross Carrying Amount	1,090		1,224
Accumulated Amortization	636		283
7Hugs
Goodwill and Intangible Assets [Line Items]
Goodwill, Acquired During Period	21,840
Gross carrying amounts and amortization of intangibles
Goodwill, Acquired During Period		$ 21,840
Infrastructure and Defense Products
Gross carrying amounts and amortization of intangibles
Goodwill, Foreign Currency Translation Gain (Loss)	0
Goodwill, Acquired During Period	608,325		608,842
Goodwill, Period Increase (Decrease)	(517)
Infrastructure and Defense Products \| 7Hugs
Goodwill and Intangible Assets [Line Items]
Goodwill, Acquired During Period	0
Mobile Products
Gross carrying amounts and amortization of intangibles
Goodwill, Foreign Currency Translation Gain (Loss)	9,185
Goodwill, Acquired During Period	2,034,383		$ 2,005,432
Goodwill, Period Increase (Decrease)	(2,074)
Mobile Products \| 7Hugs
Goodwill and Intangible Assets [Line Items]
Goodwill, Acquired During Period	$ 21,840

Goodwill and Intangible Assets (Details 2) $ in Thousands	Apr. 03, 2021 USD ($)
Estimated Amortization Expense
Finite-Lived Intangible Asset, Expected Amortization, Year One	$ 122,000
Finite-Lived Intangible Asset, Expected Amortization, Year Two	106,000
Finite-Lived Intangible Asset, Expected Amortization, Year Three	94,000
Finite-Lived Intangible Asset, Expected Amortization, Year Four	79,000
Finite-Lived Intangible Asset, Expected Amortization, Year Five	$ 73,000

Goodwill and Intangible Assets (Details 3) - USD ($) $ in Thousands	12 Months Ended
	Apr. 03, 2021	Mar. 28, 2020	Mar. 30, 2019
Goodwill and Intangible Assets [Line Items]
Intangible assets amortization	$ 252,898	$ 247,299	$ 454,451
In-process research and development
Goodwill and Intangible Assets [Line Items]
IPRD	9,600	9,606
In Process Research and Development, net of translations
Goodwill and Intangible Assets [Line Items]
IPRD	$ 9,695
Order or Production Backlog
Goodwill and Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		$ 1,600

Goodwill and Intangible Assets (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Apr. 03, 2021	Mar. 28, 2020	Mar. 30, 2019
Goodwill and Intangible Assets [Line Items]
Goodwill	$ 2,642,708	$ 2,614,274
Accumulated impairment losses and write-offs	621,600	621,600
Amortization of Intangible Assets	252,898	247,299	$ 454,451
Mobile Products
Goodwill and Intangible Assets [Line Items]
Goodwill	2,034,383	2,005,432
Infrastructure and Defense Products
Goodwill and Intangible Assets [Line Items]
Goodwill	$ 608,325	$ 608,842

Investments and Fair Value Measurements (Details) - USD ($) $ in Thousands	12 Months Ended
	Apr. 03, 2021	Mar. 28, 2020	Mar. 30, 2019
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Cost-method Investments, Other than Temporary Impairment	$ 2,775	$ 18,339	$ 0
Proceeds from Limited Partnership Investments	5,900
Equity Method Investments	29,800	14,200
Equity Securities, FV-NI, Unrealized Gain (Loss)	21,500
Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Deferred compensation plan assets	32,824	19,398
Business Combination, Contingent Consideration, Liability, Noncurrent		5,700
Business Combination, Contingent Consideration, Liability, Current	(10,000)
Fair Value, Recurring [Member] \| Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Deferred compensation plan assets	32,824	19,398
Business Combination, Contingent Consideration, Liability, Noncurrent		0
Business Combination, Contingent Consideration, Liability, Current	0
Fair Value, Recurring [Member] \| Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Deferred compensation plan assets	0	0
Business Combination, Contingent Consideration, Liability, Noncurrent		0
Business Combination, Contingent Consideration, Liability, Current	0
Fair Value, Recurring [Member] \| Fair Value, Inputs, Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Deferred compensation plan assets	0	0
Business Combination, Contingent Consideration, Liability, Noncurrent		5,700
Business Combination, Contingent Consideration, Liability, Current	(10,000)
Equity Securities \| Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Marketable Securities	3,802	459
Equity Securities \| Fair Value, Recurring [Member] \| Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Marketable Securities	3,802	459
Equity Securities \| Fair Value, Recurring [Member] \| Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Marketable Securities	0	0
Equity Securities \| Fair Value, Recurring [Member] \| Fair Value, Inputs, Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Marketable Securities	$ 0	$ 0

Leases (Details) - USD ($) $ in Thousands	12 Months Ended
Leases (Details) - USD ($) $ in Thousands	Apr. 03, 2021	Mar. 28, 2020
Lessee, Lease, Description [Line Items]
Operating lease expense	$ 17,382	$ 15,184
Short-term lease expense	7,062	6,878
Variable lease expense	3,972	3,098
Operating Lease, Payments	18,697	16,504
Operating lease assets obtained in exchange for new lease liabilities	$ 12,899	$ 13,201
Weighted-average remaining lease term (years) - operating leases	7 years 10 months 24 days	7 years 9 months 18 days
Weighted-average discount rate - operating leases	3.82%	4.06%
Less imputed interest	$ (10,603)
2022	17,194
2023	12,608
2024	9,823
2025	7,715
2026	7,603
Thereafter	23,900
Total lease payments	78,843
Present value of lease liabilities	68,240
Lessee, Finance Lease, Lease Note yet Commenced, ROU assets and lease liabilities to be recognized	$ 12,500
Lessee, Finance Lease, Term of Contract	5 years
Years elected to pay Transitional Repatriation Tax	8 years
Other Current Liabilities
Lessee, Lease, Description [Line Items]
Current operating lease liability	$ 15,068	$ 15,917
Other Noncurrent Assets [Member]
Lessee, Lease, Description [Line Items]
Operating lease asset	62,925	65,107
Other Noncurrent Liabilities
Lessee, Lease, Description [Line Items]
Non-current operating lease liability	$ 53,172	$ 58,077
Maximum
Lessee, Lease, Description [Line Items]
Lessee, Finance Lease, Term of Contract	30 years

Debt (Details)						3 Months Ended	12 Months Ended
Debt (Details)	Dec. 01, 2020 USD ($)	Oct. 16, 2020 USD ($)	Sep. 29, 2020 USD ($)	Jun. 11, 2020 USD ($)	Jul. 16, 2018	Apr. 03, 2021 USD ($)	Apr. 03, 2021 USD ($)	Mar. 28, 2020 USD ($)	Mar. 30, 2019 USD ($)	Apr. 03, 2021 USD ($)	Mar. 28, 2020 USD ($)	Dec. 20, 2019 USD ($)	Sep. 30, 2019 USD ($)	Nov. 19, 2015
Debt Instrument [Line Items]
Total long-term debt						$ 1,742,550,000	$ 1,742,550,000	$ 1,567,231,000		$ 1,742,550,000	$ 1,567,231,000
Gain (Loss) on Extinguishment of Debt							(61,991,000)	0	$ (90,201,000)
Interest Expense, Borrowings							79,300,000	66,000,000.0	52,800,000
Long-term Debt, Current Maturities										5,092,000	6,893,000
Net carrying amount of debt						1,742,550,000	1,742,550,000	1,567,231,000
Proceeds from borrowings and debt issuances (Note 9)							1,206,750,000	659,000,000	905,350,000
Line of Credit Facility, Remaining Borrowing Capacity			$ 500,000,000.0
Unamortized premium and issuance costs, net										1,475,000	1,532,000
Term Loan [Member]
Debt Instrument [Line Items]
Total long-term debt						197,500,000	197,500,000	100,000,000		197,500,000	100,000,000
Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months										5,000,000
Net carrying amount of debt						197,500,000	197,500,000	100,000,000
Proceeds from borrowings and debt issuances (Note 9)			$ 200,000,000.0
Long-term Debt, Maturities, Repayments of Principal in Rolling Year Two										7,500,000
Long-term Debt, Maturities, Repayments of Principal in Rolling Year Three										7,500,000
Long-term Debt, Maturities, Repayments of Principal in Rolling Year Four										10,000,000
Long-term Debt, Maturities, Repayments of Principal in Rolling Year Five										167,500,000
Unsecured Debt										197,500,000
Repayments of Lines of Credit							2,500,000
7.00% Senior Notes due 2025
Debt Instrument [Line Items]
Total long-term debt						0	0	23,404,000		0	23,404,000
Gain (Loss) on Extinguishment of Debt							1,000,000.0
Redemption Premium							800,000
Write off of deferred issuance costs and bond premium							200,000
Interest Paid, Including Capitalized Interest, Operating and Investing Activities								1,600,000	29,100,000
Debt Instrument, Interest Rate, Stated Percentage														7.00%
Long-term Debt, Fair Value											23,900,000
Debt Instrument, Redemption Price, Percentage	103.50%
Repayments of Senior Debt	$ 23,400,000
Interest paid								1,600,000	29,100,000
Net carrying amount of debt						0	0	23,404,000
5.5% Senior Notes due 2026
Debt Instrument [Line Items]
Total long-term debt		$ 900,000,000.0				0	0	900,000,000		0	900,000,000
Gain (Loss) on Extinguishment of Debt							61,000,000.0
Redemption Premium							57,300,000
Write off of deferred issuance costs and bond premium							3,700,000
Interest Paid, Including Capitalized Interest, Operating and Investing Activities							37,300,000	49,500,000	17,200,000
Debt Instrument, Interest Rate, Stated Percentage			3.375%		5.50%
Long-term Debt, Fair Value											962,800,000
Debt Instrument, Redemption Price, Percentage		106.363%
Interest paid							37,300,000	49,500,000	$ 17,200,000
Net carrying amount of debt		$ 900,000,000.0				0	0	900,000,000
Senior Notes Due 2029 4.375% [Member]
Debt Instrument [Line Items]
Total long-term debt						850,000,000	850,000,000	550,000,000		850,000,000	550,000,000
Interest Paid, Including Capitalized Interest, Operating and Investing Activities							31,600,000
Debt Instrument, Face Amount				$ 300,000,000.0								$ 200,000,000.0	$ 350,000,000.0
Debt Instrument, Interest Rate, Stated Percentage													4.375%
Long-term Debt, Fair Value										905,300,000	489,500,000
Debt Instrument, Redemption Price, Percentage				104.375%
Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed			40.00%		35.00%
Interest paid							31,600,000
Net carrying amount of debt						850,000,000	850,000,000	550,000,000
Debt Instrument, Redemption Price, Percentage, Excluding Make-Whole Premium				1
Credit Agreement [Member] \| Federal Funds Rate
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate			0.50%
Credit Agreement [Member] \| Eurodollar
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate			1.00%
Credit Agreement [Member] \| Maximum \| Eurodollar
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			1.25%
Credit Agreement [Member] \| Maximum \| Base Rate
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			0.25%
Credit Agreement [Member] \| Maximum \| Loan Lending Commitment Arrangement Fees
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			0.20%
Credit Agreement [Member] \| Minimum \| Eurodollar
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			1.00%
Credit Agreement [Member] \| Minimum \| Base Rate
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			0.00%
Credit Agreement [Member] \| Minimum \| Loan Lending Commitment Arrangement Fees
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			0.15%
Finance leases [Member]
Debt Instrument [Line Items]
Total long-term debt						1,617,000	1,617,000	2,252,000		1,617,000	2,252,000
Net carrying amount of debt						1,617,000	1,617,000	2,252,000
3.375% Senior Notes due 2031
Debt Instrument [Line Items]
Total long-term debt						700,000,000	700,000,000	0		700,000,000	$ 0
Interest Paid, Including Capitalized Interest, Operating and Investing Activities							11,900,000
Debt Instrument, Face Amount			$ 700,000,000.0
Long-term Debt, Fair Value										$ 689,500,000
Debt Instrument, Redemption Price, Percentage			103.375%
Interest paid							11,900,000
Net carrying amount of debt						700,000,000	700,000,000	0
Debt Instrument, Redemption Price, Percentage, Excluding Make-Whole Premium			1
Senior Notes
Debt Instrument [Line Items]
Interest Costs Capitalized							4,100,000	$ 5,600,000
2017 term loan
Debt Instrument [Line Items]
Repayments of Lines of Credit							2,500,000
Revolving Credit Facility
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity			$ 300,000,000.0
Proceeds from Lines of Credit							0
Senior Delayed Draw Term Loan
Debt Instrument [Line Items]
Repayments of Debt			97,500,000
Standby Letters of Credit
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity			25,000,000.0
Swingline Loan
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity			10,000,000.0
Term Loan [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity			$ 200,000,000.0
Interest Paid, Including Capitalized Interest, Operating and Investing Activities						2,100,000	2,400,000
Interest paid						$ 2,100,000	$ 2,400,000

Retirement Benefit Plans (Details) $ in Millions	12 Months Ended
Retirement Benefit Plans (Details) $ in Millions	Apr. 03, 2021 USD ($)	Mar. 28, 2020 USD ($)	Mar. 30, 2019 USD ($)
Retirement Benefit Plan (Textual)
Defined Contribution Plan, Company Contribution Amount	$ 15.6	$ 14.4	$ 14.0
Defined Benefit Pension Plan, Net Periodic Benefit Cost	0.6	0.6	$ 0.5
Non-Qualified Deferred Compensation Plan [Member]
Retirement Benefit Plan (Textual)
Assets held in rabbi trust	32.8	19.4
Assets held in rabbi trust, current	1.2	0.9
Assets held in rabbi trust, noncurrent	31.6	18.5
Foreign Plan [Member]
Retirement Benefit Plan (Textual)
Defined benefit plan insurance receivable	3.8	3.6
Defined Benefit Pension Plan, Benefit Obligation	$ 14.0	$ 12.3
Number of retirement benefit plans offered by the Company	2

Commitments and Contingent Liabilities (Details) $ in Millions	Apr. 03, 2021 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Purchase Obligation	$ 419.2

Restructuring (Details) - USD ($) $ in Thousands	12 Months Ended
Restructuring (Details) - USD ($) $ in Thousands	Apr. 03, 2021	Mar. 28, 2020	Mar. 30, 2019
Restructuring Cost and Reserve [Line Items]
Payments for Restructuring	$ (3,615)	$ (18,811)
Restructuring related charges	2,722	47,869	$ 50,700
Restructuring obligations	938	1,998	8,614
Transfer to right-of-use asset		(1,248)
Restructuring Reserve, Non-Cash Activity	(167)	(34,426)
Accelerated depreciation
Restructuring Cost and Reserve [Line Items]
Payments for Restructuring	0	0
Restructuring related charges	0	26,061
Restructuring obligations	0	0	0
Transfer to right-of-use asset		0
Restructuring Reserve, Non-Cash Activity	0	(26,061)
One-time termination benefits
Restructuring Cost and Reserve [Line Items]
Payments for Restructuring	(2,206)	(11,549)
Restructuring related charges	1,254	6,289
Restructuring obligations	776	1,728	6,988
Transfer to right-of-use asset		0
Restructuring Reserve, Non-Cash Activity	0	0
Contract Termination [Member]
Restructuring Cost and Reserve [Line Items]
Payments for Restructuring	(1,409)	(7,262)
Restructuring related charges	1,468	15,519
Restructuring obligations	162	270	1,626
Transfer to right-of-use asset		(1,248)
Restructuring Reserve, Non-Cash Activity	(167)	8,365
Other restructuring
Restructuring Cost and Reserve [Line Items]
Restructuring related charges	1,400	800	5,800
Fiscal Year 2019
Restructuring Cost and Reserve [Line Items]
Restructuring related charges	1,350	47,105	44,902
Restructuring and Related Cost, Cost Incurred to Date	93,400
Restructuring and Related Cost, Expected Cost Remaining	100
Fiscal Year 2019 \| Accelerated depreciation
Restructuring Cost and Reserve [Line Items]
Restructuring related charges		26,061
Fiscal Year 2019 \| One-time termination benefits
Restructuring Cost and Reserve [Line Items]
Restructuring related charges	161	6,013	7,655
Fiscal Year 2019 \| Contract Termination [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring related charges	1,189	15,031
Fiscal Year 2019 \| Accelerated Depreciation and Impairment Charges [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring related charges			37,247
Fiscal Year 2019 \| Cost of sales
Restructuring Cost and Reserve [Line Items]
Restructuring related charges	0	34,426	21,346
Fiscal Year 2019 \| Cost of sales \| Accelerated depreciation
Restructuring Cost and Reserve [Line Items]
Restructuring related charges		26,061
Fiscal Year 2019 \| Cost of sales \| One-time termination benefits
Restructuring Cost and Reserve [Line Items]
Restructuring related charges	0	0	0
Fiscal Year 2019 \| Cost of sales \| Contract Termination [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring related charges	0	8,365
Fiscal Year 2019 \| Cost of sales \| Accelerated Depreciation and Impairment Charges [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring related charges			21,346
Fiscal Year 2019 \| Other operating expense
Restructuring Cost and Reserve [Line Items]
Restructuring related charges	1,350	12,679	23,556
Fiscal Year 2019 \| Other operating expense \| Accelerated depreciation
Restructuring Cost and Reserve [Line Items]
Restructuring related charges		0
Fiscal Year 2019 \| Other operating expense \| One-time termination benefits
Restructuring Cost and Reserve [Line Items]
Restructuring related charges	161	6,013	7,655
Fiscal Year 2019 \| Other operating expense \| Contract Termination [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring related charges	$ 1,189	$ 6,666
Fiscal Year 2019 \| Other operating expense \| Accelerated Depreciation and Impairment Charges [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring related charges			$ 15,901

Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Apr. 03, 2021	Mar. 28, 2020	Mar. 30, 2019
Income (loss) before income taxes
United States	$ 125,362	$ (226,005)	$ (297,975)
Foreign	682,018	621,094	389,767
Income before income taxes	807,380	395,089	91,792
Valuation Allowance [Line Items]
Deferred income tax liability, deferred intercompany revenue	(22,284)	0
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued	6,200	$ 5,400	$ 4,400
Unrecognized Tax Benefits, Income Tax Penalties and Interest, Expected to be recognized within 12 months	5,300
Unrecognized Tax Benefits, Expected to be Recognized Within the Next 12 Months	$ 2,200

Income Taxes (Details 1) - USD ($) $ in Thousands	12 Months Ended
Income Taxes (Details 1) - USD ($) $ in Thousands	Apr. 03, 2021	Mar. 28, 2020	Mar. 30, 2019
Current (expense) benefit:
Federal	$ (11,043)	$ (6,705)	$ 17,222
State	(140)	(93)	209
Foreign	(80,722)	(65,065)	(46,267)
Total current (expense) benefit	(91,905)	(71,863)	(28,836)
Deferred (expense) benefit:
Federal	(35,545)	7,826	55,833
State	(3,771)	4,603	946
Foreign	57,452	(1,330)	13,390
Total deferred (expense) benefit	18,136	11,099	70,169
Income tax expense (benefit)	$ 73,769	$ 60,764	$ (41,333)

Income Taxes (Details 2) - USD ($) $ in Thousands	12 Months Ended
Income Taxes (Details 2) - USD ($) $ in Thousands	Apr. 03, 2021	Mar. 28, 2020	Mar. 30, 2019
ReconciliationOfProvisionOfIncomeTaxes [Line Items]
Document Fiscal Year Focus	2021
Deferred Income Tax Expense (Benefit)	$ (18,136)	$ (11,099)	$ (70,169)
Income tax expense at statutory federal rate	$ (169,550)	$ (82,969)	$ (19,276)
Income tax expense at statutory federal rate, Percentage	21.00%	21.00%	21.00%
Decrease (increase) resulting from:
State benefit (provision), net of federal (provision) benefit	$ (743)	$ 2,605	$ 710
State benefit (provision), net of federal (provision) benefit, Percentage	0.10%	(0.70%)	(0.80%)
Effective Income Tax Rate Reconciliation, Tax Credit, Amount	$ 92,532	$ 64,017	$ 69,856
Effective Income Tax Rate Reconciliation, Tax Credit, Percent	(11.50%)	(16.20%)	(76.10%)
Effect of changes in income tax rate applied to net deferred tax assets	$ 22,286	$ (2,269)	$ 12,972
Effect of changes in income tax rate applied to net deferred tax assets, Percentage	(2.80%)	0.60%	(14.10%)
Foreign tax rate difference	$ 85,851	$ 75,247	$ 41,672
Foreign tax rate difference, Percentage	(10.60%)	(19.00%)	(45.40%)
Foreign permanent differences, amount	$ 9,026	$ (5,446)	$ 6,825
Foreign permanent differences, percent	(1.10%)	1.40%	(7.40%)
Change in valuation allowance	$ (1,232)	$ 6,438	$ 2,353
Change in valuation allowance, Percentage	0.20%	(1.60%)	(2.60%)
Effective income tax rate reconciliation, expiration of state attributes, amount	$ (1,656)	$ (5,165)	$ 0
Effective income tax rate reconciliation, expiration of state attributes, percent	0.20%	1.30%	0.00%
Stock-based compensation	$ 9,545	$ (1,707)	$ (7,694)
Share-based compensation, Percentage	(1.20%)	0.40%	8.40%
Tax reserve adjustments	$ (9,979)	$ (13,973)	$ 5,213
Tax reserve adjustments, Percentage	1.20%	3.50%	(5.70%)
Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount	$ (100,830)	$ (81,916)	$ (76,215)
Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent	12.50%	20.80%	83.00%
U.S. Tax Toll Charge	$ 0	$ 0	$ 1,897
U.S. Tax Toll Charge, Percent	0.00%	0.00%	(2.10%)
Intra-entity transfer	$ 0	$ 0	$ 3,935
Intra-entity transfer, percent	0.00%	0.00%	(4.30%)
Effective income tax rate reconciliation, permanent reinvestment assertion, amount	$ (8,488)	$ (6,814)	$ 0
Effective income tax rate reconciliation, permanent reinvestment assertion, percent	1.10%	1.70%	0.00%
Effective income tax rate reconciliation, Acquisition related adjustments, amount	$ (919)	$ (7,257)	$ 0
Effective income tax rate reconciliation, Acquisition related adjustments, percent	0.10%	1.80%	0.00%
Other income tax benefit (expense)	$ 388	$ (1,555)	$ (915)
Other income tax benefit (expense), Percentage	(0.10%)	0.40%	1.10%
Income tax expense (benefit)	$ (73,769)	$ (60,764)	$ 41,333
Total, Percentage	9.10%	15.40%	(45.00%)

Income Taxes (Details 3) - USD ($) $ in Thousands	Apr. 03, 2021	Mar. 28, 2020
Deferred income tax assets:
Inventory reserve	$ 9,632	$ 10,114
Equity compensation	14,444	18,817
Net operating loss carry-forwards	24,474	71,928
Research and other credits	106,825	106,958
Employee benefits	19,357	12,606
Lease liabilities	15,947	16,456
Other deferred assets	8,662	3,559
Total deferred income tax assets	199,341	240,438
Valuation allowance	(36,512)	(35,280)
Total deferred income tax assets, net of valuation allowance	162,829	205,158
Deferred income tax liabilities:
Amortization and purchase accounting basis difference	(25,553)	(107,517)
Accumulated depreciation/basis difference	(59,756)	(59,356)
Accrued tax on unremitted foreign earnings	(21,747)	(15,521)
Right-of-use assets	(14,663)	(14,400)
Other deferred liabilities	1,681	1,955
Total deferred income tax liabilities	(145,684)	(198,749)
Deferred Tax Assets, Net	17,145	6,409
Amounts included in consolidated balance sheets:
Other non-current assets	59,056	45,754
Other long-term liabilities	$ 41,911	$ 39,345

Income Taxes (Details 4) - USD ($) $ in Thousands	12 Months Ended
Income Taxes (Details 4) - USD ($) $ in Thousands	Apr. 03, 2021	Mar. 28, 2020	Mar. 30, 2019
Reconciliation of gross unrecognized tax benefits
Beginning balance	$ 119,222	$ 103,178	$ 122,823
Additions based on positions related to current year	10,048	10,357	7,193
Additions for tax positions in prior years	6,240	6,484	8,369
Reductions for tax positions in prior years	(348)	(69)	(24,932)
Expiration of statute of limitations	(1,094)	(728)	(6,972)
Settlements	0	0	(3,303)
Ending balance	$ 134,068	$ 119,222	$ 103,178

Income Taxes (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Apr. 03, 2021	Mar. 28, 2020	Mar. 30, 2019	Mar. 31, 2018
Income Taxes (Textual)
Valuation Allowance	$ 36,512	$ 35,280
Valuation Allowance, Deferred Tax Asset, Change in Amount	(1,200)	5,200	$ 2,400
Loss carryovers	22,100
Foreign jurisdiction exemption reduction, Dollar Amount	74,300	62,900
Gross unrecognized tax benefits	134,068	119,222	103,178	$ 122,823
Unrecognized tax benefits, if recognized, would impact the effective tax rate	128,700	114,800	99,100
Interest and penalties expense (benefit) recognized related to uncertain tax positions	(800)	(700)	200
Accrued interest and penalties related to unrecognized tax benefits	6,200	5,400	4,400
Long-term Tax Liability	21,200
Taxes Payable, Current	86,700	50,800
Income Taxes Receivable, Current	3,500	5,400
Long-term income taxes payable	5,400	5,600
Income tax expense (benefit)	73,769	60,764	(41,333)
Deferred Income Tax Expense (Benefit)	(18,136)	(11,099)	(70,169)
Tax settlement	0	0	3,303
Unrecognized Tax Benefits, Increase Resulting from Acquisition	500
Cavendish [Member]
Income Taxes (Textual)
Deferred Income Taxes and Tax Credits	22,100
U.S. Tax Cuts and Jobs Act, Effective 2018 [Member]
Income Taxes (Textual)
Valuation Allowance, Deferred Tax Asset, Change in Amount			(15,100)
Domestic deferred tax assets
Income Taxes (Textual)
Valuation Allowance	33,600	31,500	39,300
Tax rate changes [Member]
Income Taxes (Textual)
Valuation Allowance, Deferred Tax Asset, Change in Amount			(1,500)
Foreign deferred tax assets
Income Taxes (Textual)
Valuation Allowance	2,900	3,800	1,100
State net operating losses and credits
Income Taxes (Textual)
Valuation Allowance, Deferred Tax Asset, Change in Amount	(2,100)	7,900
Foreign net operating losses
Income Taxes (Textual)
Valuation Allowance, Deferred Tax Asset, Change in Amount	900	$ (2,700)	$ 900
U.S. Federal
Income Taxes (Textual)
Loss carryovers	28,500
State
Income Taxes (Textual)
Loss carryovers	139,900
Research Tax Credit Carryforward [Member]
Income Taxes (Textual)
Income tax credits	150,700
Foreign deferred tax assets
Income Taxes (Textual)
Loss carryovers	115,800
State
Income Taxes (Textual)
Income tax credits	$ 65,000
Basic
Income Taxes (Textual)
Foreign jurisdiction exemption reduction, per share amount	$ 0.65	$ 0.54
Diluted
Income Taxes (Textual)
Foreign jurisdiction exemption reduction, per share amount	$ 0.64	$ 0.53

Net Income (Loss) Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Apr. 03, 2021	Mar. 28, 2020	Mar. 30, 2019
Numerator:
Numerator for basic and diluted net (loss) income per share - net (loss) income available to common stockholders	$ 733,611	$ 334,325	$ 133,125
Denominator:
Denominator for basic net (loss) income per share — weighted average shares	114,034	117,007	124,534
Effect of dilutive securities:
Stock-based awards	1,982	2,286	2,822
Denominator for diluted net (loss) income per share — adjusted weighted average shares and assumed conversions	116,016	119,293	127,356
Basic net (loss) income per share	$ 6.43	$ 2.86	$ 1.07
Diluted net (loss) income per share	$ 6.32	$ 2.80	$ 1.05

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794

+ Details

Net Income (Loss) Per Share (Details Textual) - shares shares in Millions	12 Months Ended
	Apr. 03, 2021	Mar. 28, 2020	Mar. 30, 2019
Earnings Per Share [Abstract]
Shares excluded from the computation of diluted shares outstanding	0.1	0.1	0.3

Stock-Based Compensation (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Apr. 03, 2021	Mar. 28, 2020	Mar. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance at beginning balance, Shares	2,091,000
Balance at beginning balance, Weighted-Average Grant-Date Fair Value	$ 72.59
Granted, Shares	799,000
Granted, Weighted-Average Grant-Date Fair Value	$ 125.43
Vested, Shares	(965,000)
Vested, Weighted-Average Grant-Date Fair Value	$ 70.07
Forfeited, Shares	(66,000)
Forfeited, Weighted-Average Grant-Date Fair Value	$ 86.02
Balance at ending balance, Shares	1,859,000	2,091,000
Balance at ending balance, Weighted-Average Grant-Date Fair Value	$ 93.22	$ 72.59
Outstanding beginning balance, Shares	967,000
Outstanding beginning balance, Weighted-Average Exercise Price	$ 18.11
Granted, Shares	0
Granted, Weighted-Average Exercise Price	$ 0
Exercised, Shares	(503,000)
Exercised, Weighted-Average Exercise Price	$ 18.88
Canceled, Shares	(6,000)
Canceled, Weighted-Average Exercise Price	$ 22.13
Forfeited, Shares	0
Forfeited, Weighted-Average Exercise Price	$ 0
Outstanding ending balance, Shares	458,000	967,000
Outstanding ending balance, Weighted-Average Exercise Price	$ 17.21	$ 18.11
Outstanding ending balance, Weighted-Average Remaining Contractual Term	1 year 7 months 20 days
Outstanding ending balance, Aggregate Intrinsic Value	$ 80,465
Vested and expected to vest, Shares	458,000
Vested and expected to vest, Weighted-Average Exercise Price	$ 17.21
Vested and expected to vest, Weighted-Average Remaining Contractual Term	1 year 7 months 20 days
Vested and expected to vest, Aggregate Intrinsic Value	$ 80,465
Options exercisable, Shares	458,000
Options exercisable, Weighted-Average Exercise Price Ending Balance	$ 17.21
Options exercisable, Weighted-Average Remaining Contractual Term Ending Balance	1 year 7 months 20 days
Options exercisable, Aggregate Intrinsic Value	$ 80,465
Number of shares available for grant or issuance	3,866,000
Shares granted	0
Stock-based compensation expense	$ 89,322	$ 75,978	$ 71,580
Closing stock price	$ 192.90
Total intrinsic value of options exercised	$ 66,700	65,100	37,900
Cash received from the exercise of stock options (excluding accrued unremitted employee funds)	$ 40,900
Annual forfeiture rate	1.40%
Total fair value of vested restricted stock units	$ 121,800	$ 67,700	$ 77,500
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total remaining unearned compensation cost related to nonvested restricted stock unit	$ 103,700
Weighted-average remaining service period of unearned compensation costs related to nonvested restricted stock units	1 year 2 months 12 days
Vesting period	4 years
Performance and service-based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	2 years
Certain officers of the Company (Section 16 Officers)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, Shares	200,000
Shares granted	200,000
Stock-based compensation expense	$ 27,400
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant or issuance	3,300,000
Share-based Compensation Arrangement by Share-based Payment Award, Percent of Market Price	85.00%
Shares issued under plan	400,000	500,000	500,000
2009 and 2012 Incentive Plans - TriQuint
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant or issuance	0
Share-based Compensation Arrangement by Share-based Payment Award, Percent of Market Price	100.00%
Expected term (in years)	10 years
2013 Incentive Plan - Qorvo
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant or issuance	900,000
Share-based Compensation Arrangement by Share-based Payment Award, Percent of Market Price	100.00%
Expected term (in years)	10 years
2015 Inducement Stock Plan - Qorvo
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, Shares	0	0	0
Number of shares available for grant or issuance	300,000
Maximum number of shares of common stock to be issued under plan	300,000
Shares granted	0	0	0
2012 Stock Incentive Plan - Qorvo
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant or issuance	2,700,000
Maximum number of shares of common stock to be issued under plan	4,300,000
2012 Stock Incentive Plan - Qorvo \| Performance-based restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, Shares	200,000
Shares granted	200,000
2003 Stock Incentive Plan - RF Micro Devices
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant or issuance	0

Stockholders' Equity (Details) - shares shares in Thousands	Apr. 03, 2021	Mar. 28, 2020
Common stock reserved for future issuance
Outstanding stock options under formal directors’ and employees’ stock option plans	458	967
Possible future issuance under Company stock incentive plans	3,866
Employee stock purchase plan	3,257
Restricted stock-based units granted	1,859	2,091
Total shares reserved	9,440

Stockholders' Equity (Details Textual) - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Apr. 03, 2021	Mar. 28, 2020	Mar. 30, 2019	Oct. 31, 2019
Shareholders' Equity (Textual)
Stock Repurchased During Period, Shares	(3,642)	(6,441)	(9,095)
Document Fiscal Year Focus	2021
Stock Repurchased During Period, Value	$ 515,084	$ 515,131	$ 638,074
Document Period End Date	Apr. 03, 2021
Common stock reserved for future issuance	9,440
Common stock, shares authorized	405,000	405,000
May 2018 Program
Shareholders' Equity (Textual)
Stock Repurchase Program, Remaining Authorized Repurchase Amount				$ 117,000
October 2019 Program [Member]
Shareholders' Equity (Textual)
Share repurchase program, authorized amount				$ 1,000,000
Common Stock [Member]
Shareholders' Equity (Textual)
Stock Repurchased During Period, Value	$ 136,568	$ 501,868	$ 638,074

Operating Segment and Geographical Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Apr. 03, 2021	Mar. 28, 2020	Mar. 30, 2019
Segment Reporting Information [Line Items]
Revenues	$ 4,015,307	$ 3,239,141	$ 3,090,325
Operating income	906,627	423,216	216,466
Interest expense	(75,198)	(60,392)	(43,963)
Other (expense) income	(24,049)	32,265	(80,711)
(Loss) income before income taxes	807,380	395,089	91,792
Long-lived tangible assets	1,266,031	1,259,203
Share-based Payment Arrangement, Noncash Expense	(89,322)	(75,978)	(71,580)
Amortization of Intangible Assets	(252,898)	(247,299)	(454,451)
United States
Segment Reporting Information [Line Items]
Revenues	1,631,110	1,468,358	1,379,528
CHINA
Segment Reporting Information [Line Items]
Revenues	1,579,017	1,106,679	1,094,061
Long-lived tangible assets	200,346	166,524
Other Asia
Segment Reporting Information [Line Items]
Revenues	363,523	340,400	271,797
TAIWAN, PROVINCE OF CHINA
Segment Reporting Information [Line Items]
Revenues	248,708	169,337	188,745
Europe
Segment Reporting Information [Line Items]
Revenues	192,949	154,367	156,194
Geographic Concentration Risk [Member] \| Sales [Member] \| United States
Segment Reporting Information [Line Items]
Revenues	4,015,307	3,239,141	3,090,325
Geographic Concentration Risk [Member] \| Property, Plant and Equipment \| United States
Segment Reporting Information [Line Items]
Long-lived tangible assets	1,011,686	1,042,587
Geographic Concentration Risk [Member] \| Property, Plant and Equipment \| Other Countries
Segment Reporting Information [Line Items]
Long-lived tangible assets	53,999	50,092
All other
Segment Reporting Information [Line Items]
Asset Impairment and Accelerated Depreciation			37,246
Operating income	(385,051)	(437,593)	(609,828)
Share-based Payment Arrangement, Noncash Expense	(89,322)	(75,978)	(71,580)
Amortization of Intangible Assets	(252,137)	(246,563)	(453,515)
Business Combination, Acquisition And Integration related costs	(32,946)	(61,891)	(8,522)
Restructuring and disposal costs	(2,722)	(21,808)	(13,467)
Start-up costs	(1,731)	(712)	(18,035)
Restructuring and Related Cost, Accelerated Depreciation	0	(27,118)
Other Unallocated Income Expense	(6,193)	(3,523)	(7,463)
MP [Member] \| Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenues	2,856,813	2,397,740	2,197,660
Operating income	1,008,171	715,514	558,990
IDP [Member] \| Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenues	1,158,494	841,401	892,665
Operating income	$ 283,507	$ 145,295	$ 267,304

Subsequent Events (Details) - Subsequent Event - USD ($) $ in Thousands	Apr. 05, 2021	May 05, 2021
May 2021 Program
Subsequent Event [Line Items]
Stock Repurchase Program, Authorized Amount		$ 2,000,000
Stock Repurchase Program, Remaining Authorized Repurchase Amount		$ 236,900
NextInput
Subsequent Event [Line Items]
Payments to Acquire Businesses, Gross	$ 173,200

Label	Element	Value
Restricted Cash	us-gaap_RestrictedCash	$ 429,000
Restricted Cash	us-gaap_RestrictedCash	673,000
Restricted Cash	us-gaap_RestrictedCash	$ 347,000